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ABSTRACT OF DISSERTATION 
 
THE ROLES OF ORTHOPAEDIC PATHOLOGY AND GENETIC DETERMINANTS IN 
EQUINE CERVICAL STENOTIC MYELOPATHY 
Cervical stenotic myelopathy (CSM) is an important musculoskeletal and neurologic 
disease of the horse.  Clinical disease occurs due to malformations of the vertebrae 
in the neck causing stenosis of the cervical vertebral canal and subsequent spinal 
cord compression.  The disease is multifactorial in nature, therefore a clearer 
understanding of the etiology and pathogenesis of CSM will allow for improved 
management and therapeutic practices.  This thesis examines issues of equine CSM 
diagnosis, skeletal tissue pathology, and inherited genetic determinants utilizing 
advances in biomedical imaging technologies and equine genomics.  Magnetic 
resonance imaging (MRI) data provided a more complete assessment of the cervical 
column through image acquisition in multiple planes.  First, MRI was compared to 
standing cervical radiographs for detection of stenosis.  Using canal area or the cord 
canal area ratio, MRI more accurately predicted sites of compression in CSM cases.  
Secondly, articular process skeletal pathology localized on MRI was found to be 
more frequent and severe in CSM horses compared to controls.  In addition, lesions 
were generalized throughout the cervical column and not limited to the spinal cord 
compression sites.  A subset of lesions identified on MRI was evaluated using micro-
CT and histopathology.  Osteochondrosis, osseous cyst-like structures, fibrous tissue 
replacement of bone, and osteosclerosis were observed.  These lesions support 
likely developmental aberrations of vertebral bone and cartilage maturation with 
secondary biomechanical influences.  Bone cyst-like structures are a novel finding in 
this disease.  Finally, the long-standing question of the contribution of genetic 
determinants to CSM was investigated using a genome wide association study 
(GWAS).  Multiple significant loci were identified supporting the influence of a 
complex genetic trait in clinical disease.  A simple Mendelian trait controlled by one 
gene is unlikely given the detection of variants across multiple chromosomes.  Major 
contributions from this research include documentation of articular process bone 
and cartilage pathology in horses with CSM, support for abnormal cervical vertebrae 
development being an important contributing factor in the etiology and/or 
pathogenesis of equine CSM, and evidence that multiple genetic loci contribute to 
the CSM disease phenotype.  
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Chapter 1 
Literature Review Of Equine Cervical Stenotic Myelopathy 
Summary 
Cervical stenotic myelopathy (CSM) is a disease that affects both the 
neurological and musculoskeletal systems of horses.  A diagnosis of CSM often 
carries a guarded to poor prognosis, making this a serious problem in regards to the 
health of the horse.  A further understanding of the etiology and pathogenesis is 
needed for improved management and therapeutic practices.  This chapter will 
focus on what is known about the disease in regards to epidemiology, clinical signs, 
and diagnosis, as well as associated vertebral and spinal cord pathology.  Following 
the review will be a discussion of the long-standing questions regarding the 
pathogenesis of this disease.  At the conclusion of the chapter is an overview of the 
dissertation. 
Introduction and Background 
Cervical stenotic myelopathy is a neurologic disease characterized by 
malformations of the cervical vertebrae that lead to narrowing of the cervical spinal 
canal and subsequent compression of the spinal cord.  This cord compression 
manifests as clinical proprioceptive neurologic deficits.  Compressive myelopathy 
has been reported in horses, large breed dogs, and humans (Mayhew et al., 1978; 
Dimock and Errington, 1939; Bland, 1987; da Costa et al., 2006).  Specifically in the 
horse, CSM is thought to be a multifactorial disease with high planes of nutrition, 
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increased growth rates, alterations in zinc and copper concentrations, and genetic 
determinants involved in disease development (Nout and Reed, 2003).  Although all 
these factors are known or suspected to play a role, the exact etiology and/or 
pathogenesis that lead to clinical disease are still somewhat unclear.  Over time, CSM 
has been associated with a variety of terms, each aiming to accurately describe the 
disease.  These include cervical vertebral malformation (CVM), cervical vertebral 
compressive myelopathy (CVCM), cervical vertebral instability, cervical static 
stenosis (CSS), Wobblers Syndrome, and cervical stenotic myelopathy (CSM).  For 
unity, the term cervical stenotic myelopathy, abbreviated CSM, will be used 
throughout the thesis.   
The first reports in the literature of CSM are sporadic.  Early theories 
suggested the neurologic incoordination observed in affected horses was the result 
of a previous traumatic event (Dimock, 1950).  Colloquial terms for CSM included, 
“jinxed back” and “weak loin” in reference to the horse’s appearance (Dimock and 
Errington, 1939).  In the first comprehensive publication regarding CSM, the disease 
was described as an “equine disease characterized by a bilateral incoordination of 
the hind limbs…affected are called “wobblers”.”  This work identified weaning as a 
common time for the onset of clinical signs and breed depositions for the 
Thoroughbred and Saddlebred.  The most pertinent clinical sign was hind limb 
ataxia with occasional fore limb involvement (Dimock and Errington, 1939).  
Pathologic changes noted in this survey included abnormal stenosis of the cervical 
canal, arthritis, cervical nerve compression, and degenerative changes of the spinal 
cord on histology. 
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Epidemiology 
The epidemiology of CSM has been investigated, allowing perspective on the 
incidence and prevalence of this disease.  A retrospective study examined the types 
of neurologic diseases seen at the University of Kentucky Veterinary Diagnostic 
Laboratory over a nearly 3-year period from 2000 to 2002.  A total of 4,559 equine 
necropsies were performed during this time.  Of the total cases, 397 (8.7%) were 
determined to be of neurological origin after gross and histopathologic evaluation.  
Neurological cases were further categorized by etiology as follows: 
infectious/inflammatory, neoplastic, congenital, degenerative, traumatic and 
developmental.  A total of 158 (39.7%) of the neurologic cases were categorized as 
having a developmental etiology.  CSM was the only disease in the developmental 
category; therefore, almost 40% of all neurological cases seen in this time period 
were a due to CSM (Williams, 2003).  Although cases were limited to the central 
Kentucky area, these data support CSM as a significant neurologic disease of the 
horse.   
In addition to the previously described epidemiologic survey, two other groups 
have made efforts to examine the incidence and prevalence of CSM cases in the 
horse population.  Incidence assesses the number of new cases over a given time 
period, whereas prevalence measures cases at a defined point in time.  One 
approach examined clinical records from multiple Thoroughbred breeding farms in 
Europe and the US over a 6-year period.  The overall disease incidence was 
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determined to be 1.3% (Oswald et al., 2010).   Previous to this report, an estimated 
of 2% was published (Rooney, 1969).   
Signalment and Etiologic Factors 
Multiple publications have contributed to a strong knowledge base regarding the 
signalment of CSM horses, specifically gender, breed, and age.  A well-documented 
gender bias of male over females is established in the literature.  Gender ratios of 
affected males to females range from 3:1-23:1 (Dimock, 1950; Steel et al., 1959; 
Falco et al., 1976; Levine et al., 2007; Levine et al., 2008; Levine et al., 2010).  A 
retrospective study examining possible breed associations with CSM found 
Thoroughbreds, Warmbloods, and Tennessee Walking Horses more likely to 
develop the disease as compared to other breeds (Levine et al., 2007; Levine et al., 
2008; Levine et al., 2010).  In regards to age, historically CSM has been thought of as 
a disease of young horses often falling under the categorization of developmental 
bone diseases.  Various studies have identified the mean ages of CSM horses as less 
than 2 years (Dimock and Errington, 1939; Mayhew, 1978; Levine et al., 2008; 
Levine et al., 2010).  Recent retrospective studies have identified CSM developing in 
older horses.  That being said, odds ratios still indicate that younger horses between 
6 months and 7 years of age are more likely to develop the disease (Levine et al., 
2007; Levine et al., 2008).     
 CSM is a multifactorial disease with environmental and possibly heritable 
components (Mayhew, 1978; Falco et al., 1976; Mayhew et al., 1993).  As previously 
stated, high planes of nutrition, increased growth rates, alterations in zinc and 
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copper concentrations, and possibly genetic determinants play a role in disease 
development.  The relationship between nutrition and skeletal growth and 
maturation is established in multiple species (Kronfeld et al., 1990).  It has been 
noted that often horses with CSM are larger than age matched pasture mates.  
Commonly the disparity in size can be attributed to changes in feed to promote 
growth and maturation for performance, competition, or commercial reasons.  An 
additional report suggested horses with a heavier head and longer neck could result 
in predisposition to CSM (Rooney, 1969). 
 The role of genetic determinants in the development of CSM is a long-
standing question.  Initial support for a genetic influence came from a pedigree 
analysis that suggested a possible recessive transmission in the Thoroughbred 
(Dimock, 1950).  In contrast, a later pedigree study examined the disease in British 
Thoroughbreds and did not find evidence for genetic influences (Falco et al., 1976).  
A breeding study crossed dams (n=12) and sires (n=2), with a confirmed clinical 
diagnosis of CSM, and followed the progeny for approximately one year (Wagner et 
al., 1985).  Crossing a CSM horse with a CSM horse did not produce the disease in 
the offspring during their first year of life.  Interestingly though, the foals did have 
evidence of other developmental orthopaedic diseases such as osteochondrosis, 
contracted tendons, and physitis, indicating aberrations in cartilage and bone 
maturation.  Finally, there is strong anecdotal evidence in families across breeds for 
possible heritability.  Therefore, the exact role of genetic determinants in the 
development of CSM is still unresolved. 
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Clinical Presentation and Diagnosis 
CSM horses present with neurologic proprioceptive deficits due to cervical 
spinal cord compression.  Most commonly, the hind limb ataxia is more pronounced 
than the fore limb ataxia.  Typically, the ataxia is symmetrical in nature with regard 
to right and left sides of the horse.  Situations in which the ataxia is asymmetrical 
can result from alterations in the size or spatial positioning of the articular 
processes which causes compression of the lateral spinal cord and nerve roots 
(Moore et al., 1992).  The anatomic arrangement of nerve tracts in the spinal cord 
explains the distribution of the ataxia.  The dorsal spinocerebellar tracts that control 
proprioception in the hind limbs are located more superficially than the 
proprioceptive tracts for the forelimbs (de la Hunta, 1983) (Figure 1.1).  Therefore 
when compression occurs, the dorsal spinocerebellar tracts are the first nerves 
affected leading to development of higher grade of ataxia in the hindlimbs than the 
fore limbs. 
 
 
Figure 1.1:  Distribution of the spinocerebellar tracts in the spinal cord.  The 
spinocerebellar tracts are located on the lateral aspect of the spinal cord.  The tracts 
for the pelvic limbs are superficial to the thoracic limbs.  (Nout and Reed, 2003). 
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Diagnosis of this disease is focused on a thorough neurologic examination as 
well as radiographic imaging studies of the cervical column.  Neurologic deficits are 
graded on a scale of 0-5, with 0 being normal and 5 indicating recumbency (Mayhew, 
1978).  As mentioned previously, CSM horses often present with a bilateral 
symmetrical hind limb ataxia, with the forelimbs less severely affected.  
Identification of this type of ataxia helps to differentiate CSM from other equine 
neurologic diseases such as viral encephalitidies (Equine herpesvirus-1, Eastern 
Equine encephalitis, Western equine encephalitis, Venezuelan equine encephalitis, 
West Nile Virus, and rabies), protozoal disease (Equine protozoal 
myeloencephalitis), trauma, or bacterial causes of encephalomyelitis.  Deficits of the 
cranial nerves are typically absent with cervical stenotic myelopathy.  In addition to 
the distribution of the ataxia, evaluation of the cerebral spinal fluid (CSF) can help to 
rule in or rule out infectious etiologies of neurologic disease. 
Findings from multiple investigators have established thresholds for 
identification of vertebral canal stenosis on both standing cervical radiographs and 
myelograms.  Initially, detection of vertebral stenosis was done with semi-
quantitative methods (Mayhew et al., 1993).  A radiographic score was assigned 
based on assessment of the following parameters: stenosis of the vertebral canal, 
caudal extension of the dorsal lamina, angular fixation, enlarged vertebral physes, 
delayed bone ossification, and degenerative joint disease.  This method was 
evaluated in a survey of 132 Thoroughbred foals and found to accurately predict 
disease in horses up to one year of age.  A quantitative method evaluating the 
absolute minimal sagittal diameter of the vertebral canal on standing cervical 
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radiographs was found to have a high sensitivity and specificity for disease 
diagnosis (Mayhew, 1978).  Subsequent to this work, radiographic intravertebral 
thresholds or minimal sagittal diameter (MSD) ratios for identification of stenosis 
for specific vertebral sites were introduced (Moore et al., 1994).  The ratio 
addresses variability associated with radiographic magnification and animal size 
(Hudson and Mayhew, 2005).  The vertebral canal height divided by the height of 
the vertebral body determines the intravertebral ratio (Figure 1.2).  Established 
intravertebral thresholds for each vertebrae are as follows:  C2-3, C3-4, C4-5 < 0.50; 
C5-6 < 0.52; C6-7 < 0.56.  Therefore, a radiographic ratio less than the established 
value indicate presumptive stenosis at a vertebral site.  The sensitivity and 
specificity of this method was greater than 89% at each vertebral site.  While the 
MSD ratio evaluates the intravertebral measurements, a method has recently been 
developed to assess stenosis between vertebrae (Hahn et al., 2008).  Using the 
smallest diameter between the dorsal lamina and vertebral body of two adjacent 
vertebrae and dividing it by the height of the vertebral body gives the intervertebral 
minimal sagittal diameter ratio (Figure 1.2).  A cut off value of <0.485 is suggested 
for identification of stenosis.  
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Figure 1.2:  Two adjacent vertebrae in the sagittal plane for intravertebral and 
intervertebral ratio measurements.  The intravertebral ratio is composed of the 
vertebral canal height at the cranial or caudal end of the vertebrae (line “a”) divided 
by vertebral body height (line “d”).  Vertebral canal height (lines “b” or “c”), using 
the smaller of the two, divided by vertebral body height (line “d”) gives the 
intervertebral ratio (Adapted from Hahn et al., 2007). 
 
In addition to standing cervical radiographs, other diagnostic imaging 
techniques are available.  Cervical myelography is considered the best antemortem 
clinical diagnostic for identification of vertebral canal stenosis in the horse. 
(Rantanen et al., 1981; Papageorges et al., 1987)  In contrast to the non-invasive 
nature of cervical plain films, myelography requires anesthesia for injection of a 
radio-opaque dye into the subarachnoid space for delineation of the cervical spinal 
cord on radiographic images.  The neck is then manipulated into a variety of 
positions (neutral, flexed, and extended).  In each of these positions, radiographs are 
evaluated for attenuation of the dorsal and/or ventral dye column, suggesting 
compression of the spinal cord at a particular vertebral site(s) (Figure 1.3).   
    d 
    a 
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Figure 1.3:  Cervical myelogram in the neutral position.  The red line is located at a 
point with normal presence of the dorsal and ventral dye column (no compression).  
At the yellow line, however, there is attenuation and loss of the dorsal and ventral 
dye column suggestive of cord compression. 
 
Decision criteria for confident detection of spinal cord compression on 
myelography have been put forth in the literature (Van Biervliet et al., 2004; 
Mayhew et al., 1978; Nyland et al., 1980; Nixon et al., 1982; Papageorges et al., 1987; 
Neuwirth et al., 1992).  Such criteria include a dorsal myelographic column of <2mm 
at a vertebral site or narrowing of the dorsal and/or ventral dye columns by > 50% 
as compared to the cranial vertebral site.  Each have a varied ability to confidently 
identify spinal cord compression associated with vertebral canal stenosis.  van 
Biervliet and co-authors found a 20% reduction in the dural diameter in the flexed 
position at C6-7 to be highly sensitive and specific for cord compression due to CSM 
(van Biervliet et al., 2004).  Therefore, when evaluating the cervical column for 
vertebral canal stenosis anatomical site, position (normal, flexed, extended), and 
threshold criteria should be taken into consideration.   
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Disease Categorization 
Based on myelographic assessment, compression can be classified as 
dynamic or static.  Dynamic compression occurs when attenuation of the dye 
column happens only with the neck in the flexed or extended position.  Often, 
dynamic compression is seen in the mid cervical region, which encompasses the 
third to the fifth vertebrae.  On the other hand, if dye column attenuation is 
observed regardless of neck position, then compression is categorized as static.  
Typically this type of compression is seen in the caudal cervical column from the 
fifth to the seventh vertebrae (Mayhew, 1999).  
Consideration of the presence of specific gross pathologic lesions in the context 
of signalment lead to a classification system of Type 1 and Type 2 cervical vertebral 
malformation (CVM) (Mayhew, 1999).  Features of type 1 CVM include the 
following:  age of onset from weaning until 2 years, static or dynamic stenosis, 
pathologic changes of the articular processes such as osteochondrosis, kyphosis or 
subluxation due to vertebral body malalignment, vertebral body physitis, and caudal 
extension of the dorsal lamina into the intervertebral space.  The lesions and 
presentation of Type 1 CVM suggest a developmental aberration leading to the 
described vertebral malformations.  In contrast, Type 2 CVM typically affects older 
horses.  Vertebral lesions include osteoarthritic and degenerative changes of the 
articular processes.  Osteophytes and thickening of the articular soft tissues is 
observed along with synovial cysts.  Further descriptions of the vertebral changes 
mentioned here is in the CSM pathology section of this chapter. 
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Treatment and Management 
Several management and treatment options are available after a diagnosis of 
CSM has been made.  Selecting an appropriate option is dependent on the age of the 
horse, number of sites of compression, chronicity of clinical signs, and financial 
resources.  Medical management of the disease includes reducing inflammation 
from the repeated compression of the spinal cord.  Routine anti-inflammatory 
medications including non-steroidal anti-inflammatory drugs (NSAIDS), such as 
flunixin meglumine, and corticosteroids are used in moderate to severe cases (Nout 
et al., 2003).   
Another focus of medical management is slowing the growth rate in young 
horses, via a restricted diet to allow for bone remodeling (Donawick et al., 1989; 
Donawick et al., 1993; Kronfeld et al., 1990).  The impact of protein and energy 
restriction in young horses with either suspected or confirmed neurologic and/or 
radiographic deficits consistent with CSM has been investigated (Donawick et al., 
1989).  In addition to diet restriction, reduced exercised was also included.  The diet 
comprised 65-75% of the recommended energy and protein content, 
supplementation of copper and zinc at 2 times and 3.5 times the recommended NRC 
level respectively, and access to hay.  Conclusions from this study were that, 
although the horses became quite thin, the dietary restrictions slowed growth rates 
to allow remodeling of the vertebrae for sufficient space to negate spinal cord 
compression.  Since this study, other “paced” nutritional plans have been developed 
which reduce energy and protein intake without the dramatic weight loss (S. Reed, 
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personal communication).  Use of the “paced” diet and exercise restriction is most 
effective in horses under one year of age when maximal growth is occurring.  
In situations where nutritional management is not sufficient, surgical options are 
available, specifically cervical vertebral interbody fusion or dorsal laminectomy.  
The surgery aims to prevent further spinal cord damage by stabilizing the 
intervertebral joint and relieving cord compression.  A retrospective survey over a 
9-year period found that 77% of CSM who underwent surgery had some level of 
neurologic improvement.  Forty-three percent of horses returned to some sort of 
athletic function (Moore et al., 1993).  It was also reported in this study that the 
number of compression sites did not have an effect on the post surgical outcome.   
Cervical Vertebral Anatomy 
Before describing the pathologic vertebral changes that have been associated 
with equine CSM, a brief review of normal vertebral anatomy will be summarized.  
Seven vertebrae make up the cervical column.  Vertebrae are considered irregular 
bones due to their shape.  Other bone categories are long, flat, sesamoid, and short.  
The vertebral spinal canal is the space occupied by the spinal cord.  Vertebral arches 
(pedicles) border the spinal canal on either side.  The dorsal lamina forms the roof 
of the canal and the vertebral body comprises the floor of the canal.  Articular 
processes are located on the dorsal aspect of the vertebrae (Figure 1.4). 
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Figure 1.4:  Images of cervical vertebral anatomy.  The image on the left is a 
schematic of a single cervical vertebra in the transverse plane.  A- articular process; 
B- vertebral canal; C- vertebral body; D- vertebral arch; E- transverse process; F- 
dorsal lamina; G- spinous process (Whitwell and Dyson, 1987).  On the right, is a 
photograph of the cervical column from C2-C7 in the sagittal plane. 
 
There is a natural narrowing of the vertebral canal in the mid cervical region.  
Epiphyseal plates are located at the cranial and caudal aspect of each vertebral body.  
The cranial physis typically closes around 2 years of age in a ventral to dorsal 
direction.  In contrast, the caudal physis remains open until 4-5 years of age and 
closes in a dorsal to ventral direction (Whitwell and Dyson, 1987).  Cervical spinal 
nerves exit the vertebral canal through the intervertebral foramen.  The second 
through the seventh cervical vertebrae have articular processes located on the 
dorsal aspect.  The first cervical vertebra, commonly known as the atlas, does not 
have articular processes.  The second vertebra, called the axis, only has 2 articular 
processes, left and right, located on the caudal aspect of the vertebrae.  Whereas 
cervical vertebrae 3 through 7 have articular processes located on the left and right 
side in both the cranial and caudal positions.  The articular processes articulate with 
the same structure of the adjacent vertebrae in the cranial or caudal direction 
C2 
C3 
C4 
C5 
C6 
C7 
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forming synovial joints.  The articular process joints function to connect the 
individual vertebrae together forming the cervical vertebral column.  Other 
anatomic structures that stabilize the column include the following:  the ligamentum 
flavum, which connects dorsal laminas of adjacent vertebrae, fibrous disc material 
between each vertebral body, and a complex arrangement of skeletal muscle 
attachments. 
CSM Pathology 
Spinal Cord 
There are characteristic histopathologic lesions that indicate compressive injury 
to the spinal cord and are visualized in CSM cases.  In the white matter, Wallerian 
degeneration with the varying degrees of demyelination, presence of gitter cells, 
dilated myelin sheaths, and spheroids (swollen axons) are consistent with spinal 
cord compression (Figure 1.5).  In chronic cases, perivascular fibrosis, motor neuron 
loss, astrocytosis, and microglial scars are observed.  (Summers et al., 1995). 
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Figure 1.5: Histopathologic sections of the white matter of the spinal cord.  The 
image on the left is normal white matter at 2X magnification.  The spinal cord on the 
right is from a CSM horse at 10X magnification.  Dilated myelin sheaths (thick 
arrows), gitter cells (thin arrows), and spheroids (circle) are consistent with 
compressive spinal cord injury seen in CSM.   
 
Distribution of the lesions within the funiculi of the white matter aids in 
lesion localization.  Pathologic changes are visualized in the dorsal, lateral, and 
superficial funiculi at the compression site.  The dorsal and superficial lateral 
funiculi, which contain the ascending nerve tracts, are affected cranial to the site of 
compression, whereas the descending nerve tracts in the ventral and the deep 
portion of the lateral funiculi are affected caudal to the site of compression (Figure 
1.6). 
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Figure 1.6:  Schematic of lesion localization in the spinal cord.  Black dots indicate 
distribution of Wallerian degeneration (Mayhew, 1978). 
 
Vertebral Body 
The vertebral body can contribute to compression in several ways.  
Narrowing of the vertebral canal can occur from dorsal deviation of the vertebral 
body due to subluxation (Figure 1.7).  Also, flaring of the caudal epiphysis results in 
a focal decrease in canal height.  Histopathological changes in the vertebral body 
include increased bone known as osteosclerosis, mainly in the metaphysis, which 
leads to distortion of epiphyseal plates.  Chondronecrosis, osteonecrosis and 
retained cartilage cores have been reported in the vertebral body as well (Mayhew 
et al., 1978).   
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Figure 1.7:  Sagittal view of the cervical vertebral column demonstrating vertebral 
body subluxation.  There is upward deviation of the vertebral body into the canal 
space (arrow).  The spinal cord has been removed (Mayhew, 1999). 
 
Articular Processes 
The role of the articular processes in vertebral canal stenosis has been the 
focus of multiple investigations.  A variety of lesions have been reported including 
degenerative joint disease, subchondral osteosclerosis, osteochondrosis, synovial 
cysts, and thickening of the joint capsule.  Similar to the vertebral bodies, 
osteonecrosis, chondronecrosis, retained cartilage cores have been observed on 
histopathology (Mayhew et al., 1978; Trostle et al., 1993; Stewart et al., 1991; Fisher 
et al., 1981).  Examples of gross articular process pathology are described in figure 
1.8. 
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Figure 1.8:  Normal and gross pathology of the articular processes associated with 
cervical stenotic myelopathy.  The left picture is an articular process (formalin 
fixed) from a control horse.  The articular surface is smooth, and white with an oval 
shape.  The middle image (formalin fixed tissue) demonstrates degenerative or 
arthritic changes including cartilage loss, dull and grey discoloration, and fibrillation 
(yellow arrows).  Also, the synovium is moderately thickened (thick arrow).  The 
right image (unfixed tissue) is an articular process with osteochondrosis.  This 
lesion is characterized by invaginations of the cartilage (black arrow). 
 
Osteochondrosis is a developmental orthopaedic disease associated with a 
failure of normal endochondral ossification in cartilage and bone maturation.  
Articular process osteochondrosis in the context of CSM has been investigated as 
well.  It was found that although the frequency of articular process osteochondrosis 
did not differ between CSM and controls, the severity of osteochondrosis did.  
However both the frequency and severity of osteochondrosis in the appendicular 
skeleton was greater in CSM horses (Stewart et al., 1991).  
Alterations in the size and spatial orientation of the articular processes 
impact the space available in the vertebral canal.  Recently, the anatomy of the 
articular process joint with relationship to the spinal cord in clinically normal 
horses was evaluated with CT.  The articular process joints were distended with 
contrast media and the anatomy evaluated.  Distention caused dorsolateral 
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extension of the articular process joint into the vertebral canal.  The authors 
concluded that in the absence of pathologic changes distention of the articular 
process joint was not sufficient to cause compression.  However, it was speculated 
that in the presence of pathologic changes in regards to size or spatial orientation, 
joint space effusion could lead to compression (Claridge et al., 2010).  Finally, earlier 
work identified that malformations of the articular process joints caused lateral 
compression of the spinal cord and peripheral nerve roots exiting the intervertebral 
foramen (Moore et al., 1992). 
Dorsal Lamina and Ligamentum Flavum 
Changes to the dorsal lamina and ligamentum flavum have been described 
primarily in the caudal cervical column, often observed as static cervical stenosis.  
On gross examination, both the dorsal lamina and ligamentum flavum can be 
thickened in CSM horses.  The most common histopathologic change in the dorsal 
lamina is osteosclerosis with retained cartilage also observed (Mayhew et al., 1978; 
Powers et al., 1986).  Fibrocartilage is observed at the insertion of the ligamentum 
flavum at the dorsal lamina.  Proliferation of fibrovascular tissue is also seen 
scattered in the ligamentum flavum (Powers et al., 1986). 
Important Knowledge Gaps 
So far, this review has focused on what is known about CSM in regards to 
epidemiology, signalment, diagnosis, treatment options, and pathology.  Important 
remaining questions include the exact etiology/pathogenesis that leads to the 
development of CSM in the horse.  Environmental factors are well documented.  CSM 
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is established as a multifactorial disease but the interplay of the factors, which leads 
to clinical disease, is still unknown. 
 Two main theories have been developed to model CSM pathogenesis.  The 
first theory centers developmental abnormalities that lead to vertebral 
malformations.  Osteochondrosis, a developmental orthopaedic disease, has been 
shown to occur with increased severity in CSM horses (Stewart et al., 1991).  
Pathologic findings also support suppression of normal bone and cartilage turnover 
and maturation (Mayhew, 1978).  There is potential that these developmental issues 
could begin in utero (Mayhew, 1999).  The second theory proposes that CSM occurs 
due to abnormal stresses on the cervical column leading to vertebral malformation.  
Since the cervical vertebrae are still remodeling and developing up to approximately 
5 years of age, they are more susceptible to biomechanical forces on the neck.  
Thickening of the soft tissues, osteosclerosis of the dorsal lamina, and osteoarthritis 
are supportive of the biomechanical model (Powers et al, 1986; Trostle et al., 1993). 
Further investigation of the pathology associated with this disease could help 
provide clarity to disease mechanisms for the clinical manifestation of CSM. 
 A related major knowledge gap is the role of genetic determinants as an 
etiologic factor in disease susceptibility and/or development.  Pedigree analyses and 
anecdotal reports support a role of genetic determinants in CSM (Dimock, 1950; 
Errington, 1938).  On the other hand, a prospective breeding study minimizes the 
likelihood of CSM being inherited as a single gene trait (Wagner et al., 1985).   
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Powerful new scientific resources have been developed in recent years 
through whole genome sequencing and related advances in the field of genomics 
that provide new approaches to investigate potential genetic determinants of CSM.  
In a large collaborative project that started in late 2006, the first horse genome was 
sequenced to 6.8x coverage and assembled into the reference equine genome (Wade 
et al., 2009).  In addition to determining the primary nucleotide sequence of the 
equine genome and specific chromosomal loci for functional elements such as 
protein coding genes, this work led to the identification and characterization of 
millions of genetic polymorphisms distributed throughout the equine genome.  This 
large number of polymorphic markers enables the potential for equine linkage 
analyses, which can investigate co-segregation of genetic markers with hereditary 
traits in families.  Co-segregation studies can provide data to assess mode of 
inheritance, identify genome regions or loci of importance, and help identify 
potential candidate genes for a trait of interest.  This family-based analysis is called 
genome wide linkage study (GWLS).    
Equine breeders, however, avoid matings that might produce hereditary 
diseases.  As a result, it is often difficult to assemble kindreds to study disease traits 
using GWLS approaches.  Furthermore, incomplete penetrance and complex 
genetics will limit the effectiveness of family studies.  Fortunately, the large number 
of genetic markers allows an alternative approach based on distribution of genes 
and the traits in closed breeding populations.   Basically, individuals within a closed 
breeding population will, on average, have the same chance of possessing any of the 
genetic markers.  However, if the population is divided into two groups based on a 
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distinguishing characteristic, for example, whether or not they exhibit black-
pigmented hair, then any genetic markers that co-distribute with the trait will signal 
that the trait is genetic and that a gene controlling that trait has a locus close to that 
genetic marker.  This approach is called a genome wide association study (GWAS).  
GWAS can be very effective at uncovering individual genes regulating a trait based 
on an unambiguous phenotype with a simple pattern of Mendelian inheritance.  The 
Extension locus alleles that regulate coat color are an example (McCue et al., 2012).  
GWAS can also be applied, however, for investigating more complex genetic diseases 
where the possibility exists of multiple variants that individually have a small 
impact but collectively influence the phenotype of interest.  Nucleotide sequence 
variants distributed across the genome include single nucleotide polymorphisms 
(SNPs), copy number variants (CNVs), microsatellites, and insertion/deletion 
polymorphisms (INDELS) (Shafer and Hawkins, 1998).  SNPs are variations in a 
single base where as CNVs range in size from a couple of hundred bases to several 
megabases in length.  With the availability of these new genomic technologies and 
reagents in the horse, reexamination of the role of genetic determinants in CSM is 
justified.   
Dissertation Overview and Objectives 
 CSM is one of the most common neurologic diseases in the horse.  Depending 
on the severity of clinical signs, euthanasia is often elected for humane and safety 
reasons.  Further investigation of remaining questions regarding the interaction of 
etiologic factors and pathogenesis could help improve diagnostic, management, and 
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treatment options of this important disease.  The work presented in this thesis re-
investigates the etiology and pathogenesis of equine CSM using contemporary 
imaging and genomic techniques.   
Chapter 2:  Comparison Of Standing Cervical Radiographs And Magnetic 
Resonance Imaging For Evaluation Of Vertebral Canal Stenosis In Equine 
Cervical Stenotic Myelopathy 
 The aim of the work described in Chapter 2 was to determine if magnetic 
resonance imaging (MRI) allows for more accurate identification of cervical canal 
stenosis as compared to lateral radiographs in CSM horses.  The sensitivity and 
specificity of lateral cervical radiographs to evaluate horses suspected of cervical 
stenotic myelopathy (CSM) are limited by the assessment being restricted to the 
sagittal plane.  The ability of MRI to acquire images in multiple planes addresses this 
issue.  Radiographic cervical canal height measurements categorized by standard 
minimal sagittal diameter (MSD) intravertebral and intervertebral ratios produced 
several false positive and false negative canal stenosis determinations as defined by 
spinal cord histopathology.  Postmortem MRI measurements of canal area and cord 
canal area ratio more accurately predicted sites of cord compression in CSM cases.  
No differences in spinal cord measurements were observed when comparing CSM to 
control horses, but each of the vertebral canal parameters achieved significance at 
multiple sites.  Results from this study support vertebral canal area and cord canal 
area ratio as better parameters to predict the location of cervical canal stenosis 
compared to only the sagittal plane of canal height.  Therefore in the future, 
development of MRI or computed tomography (CT) equipment capable of 
evaluating the cervical column of adult horses will substantially enhance evaluation 
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of CSM patients.  This chapter has been published in Equine Veterinary Journal 
(Janes et al., 2013). 
Chapter 3:  Skeletal Pathology Of The Cervical Articular Processes In Equine 
Cervical Stenotic Myelopathy 
Experiments reported in chapter 3, focus on the characterization and 
evaluation of articular process skeletal pathology associated with CSM.  First, 
identified articular process pathology was assessed both quantitatively in regards to 
the number and location of lesions, and qualitatively in regards to severity.  Subsets 
of lesions were then structurally evaluated using micro-CT and routine 
histopathology methods.  It was found that lesions identified on MRI occurred at an 
increased frequency and severity in CSM horses compared to controls.  Also, 
pathology was observed both at and away from the site of compression, supporting 
a generalized problem of bone and cartilage maturation in the cervical column of 
horses with CSM.  Histologically, lesions included osteochondrosis, osseous cyst- 
like structures, fibrous replacement of trabecular bone and the bone marrow, and 
osteosclerosis.  These lesions support a disease model with developmental skeletal 
pathology as a primary issue with likely secondary biomechanical influences on the 
articular processes leading to malformations.   
Chapter 4:  The Role Of Inherited Genetic Determinants In Equine Cervical 
Stenotic Myelopathy 
 Chapter 4 re-examines the question of whether inherited genetic 
determinants contribute in a substantial way to the susceptibility, etiology, and/or 
pathogenesis of CSM.  The experiments utilized equine genomic reagents and 
protocols developed over the last several years.  Carefully phenotyped CSM horses 
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were compared to population data using the Equine SNP50 and Equine SNP 70 Bead 
Chips for a genome wide association study (GWAS).  In addition, a copy number 
variant (CNV) assessment for identification of possible unique CNVs within a family 
with increased disease prevalence was performed.  Results of the GWAS identified 
multiple significant loci composed of individual SNPs and haplotypes localized to 
several chromosomes.  Results of this study support a genetic role in the 
development of CSM, but given that interesting regions were identified across the 
genome, it is unlikely one or only a few major genes control the CSM phenotype.  
Genetic contributions are likely more complex in nature with multiple loci involved 
versus a simple Mendelian trait.  This is consistent with the understanding that 
clinical disease due to CSM is multifactorial in nature resulting from both genetic 
and environmental variables.   
 
Chapter 5:  Reflections And Future Directions 
The emphasis of this chapter will be a reflection on how experiments in this 
thesis have contributed to reducing and/or refining the existing knowledge gaps in 
our understanding of equine CSM.  In addition, possible future studies based on the 
results of this dissertation research are discussed. 
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Chapter 2 
Comparison Of Magnetic Resonance Imaging To Standing Cervical 
Radiographs For Evaluation Of Vertebral Canal Stenosis In Equine Cervical 
Stenotic Myelopathy. 
 
Summary 
Experiments in this chapter aimed to determine if magnetic resonance 
imaging (MRI) allows for the more accurate identification of cervical spinal canal 
stenosis as compared to lateral cervical radiographs in CSM horses.  In addition, a 
morphometric assessment of the vertebral canal was performed.  Nineteen 
Thoroughbred horses with CSM were compared to nine control Thoroughbreds.  
Antemortem, the subjects had neurologic examinations and standing cervical 
radiographs with sagittal ratios calculated from C3-C7.  Intact cervical column MRI 
scans and histologic examinations of the spinal cord were performed postmortem.  
Morphometric parameters were measured on the vertebral canal, spinal cord, and 
intervertebral foramen.  Radiographic cervical canal height measurements 
categorized by standard minimal sagittal diameter (MSD) intravertebral and 
intervertebral ratios produced several false positive and false negative canal 
stenosis determinations as defined by spinal cord histopathology.  Postmortem MRI 
measurements of canal area and cord canal area ratio more accurately predicted 
sites of cord compression in CSM cases.  Development of MRI or computed 
tomography (CT) equipment capable of evaluating the cervical column of adult 
horses will substantially enhance evaluation of CSM patients.   
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Introduction  
Cervical stenotic myelopathy (CSM, Wobbler Syndrome) is the result of 
malformations of the cervical vertebrae, which cause stenosis of the vertebral canal 
and compression of the spinal cord.  Compressive myelopathy has been reported in 
multiple species including horses, dogs, and humans (Mayhew, 1978; Dimock and 
Errington, 1939; Bland, 1987; da Costa et al., 2006).  CSM typically affects young 
horses with an increased incidence in certain breeds, including Thoroughbreds, 
Tennessee Walking Horses, Quarter Horses, and Warmbloods (Levine et al., 2008).  
There is a well-documented gender ratio of males over females with reports ranging 
from 3:1 up to 23:1 (Dimock, 1950; Falco et al., 1976).  CSM is a multi-factorial 
disease with genetics, high planes of nutrition, alterations in copper and zinc ratios, 
rapid growth rates, and trauma thought to potentially play a role in the etiology and 
pathogenesis.   
Several groups of researchers have made important contributions to 
antemortem diagnostic criteria of equine CSM using standing cervical lateral 
radiographs and myelography (Mayhew et al., 1993; Moore et al., 1994; Hahn et al., 
2008; van Biervliet et al., 2004).  Thresholds have been established using anatomical 
measurements converted to intravertebral and intervertebral ratios to identify 
presumptive areas of canal stenosis both at the intervertebral joint and within 
vertebrae.  With myelography, spinal cord compression can be visualized due to 
attenuation of the dorsal and/or ventral contrast medium columns and interpreted 
using published criteria for contrast medium column measurements.  Compression 
from the lateral aspect can also occur due to altered articular process shape, size, 
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and spatial positioning.  While both methods are important diagnostic aides, the 
levels of false positives and false negatives remain problematic (Papageorges et al., 
1987).  A factor contributing to this problem is the limitation of assessment to the 
sagittal plane with lateral images.  Changes in vertebral canal structure that might 
lead to spinal cord compression are not restricted to reductions in the dimension of 
dorsal-ventral height.  Dorsal ventral radiographic views can be obtained as well, 
but these views capture the articular processes and not the vertebral canal.  
Therefore, a more complete view of the cervical column should improve diagnostic 
assessment.  The ability of magnetic resonance imaging (MRI) to evaluate a 
structure of interest in multiple planes, as well as provide images of both soft tissues 
and osseous structures in situ has the potential to overcome major limitations of 
lateral radiographs when assessing equine patients for CSM.  Given these 
characteristics, this study was designed to test the hypothesis that MR imaging 
provides a more rigorous assessment of the cervical vertebral canal as compared to 
standing cervical radiographs in the horse.  The objectives were to:  1) Compare the 
ability of standing cervical radiographs and MRI to identify vertebral canal stenosis 
in horses with CSM, and 2) Evaluate anatomic parameters of the vertebral canal, 
spinal cord, and intervertebral foramen between control and CSM horses on MRI.  
 
Materials and Methods 
Animals 
Horses utilized in the study were identified based on clinical history, 
neurological assessment, cervical radiographs, and postmortem examination.  
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Nineteen Thoroughbred horses with CSM (17 males, 2 female, age range 6-50 
months with a mean of 18.1 months) were compared to nine control Thoroughbred 
horses (6 males, 3 females, age range 9-67 months with a mean of 12.4 months).  
Case and control horses were identified in collaboration with local veterinary 
practitioners.  
Clinical Examination 
A neurologic examination was performed on each horse.  A grading scale of 
0-5, where 0 indicated no neurologic deficits and 5 indicated recumbency, was used 
to classify the severity of clinical signs in the forelimbs and hind limbs (Mayhew, 
1978).  Standing lateral cervical radiography was obtained on all horses.  
Radiographic images were measured and evaluated by a single blinded assessor.   
Standard minimal sagittal diameter (MSD) intravertebral ratios (C2-C5 <0.50; C6 
<0.52; C7 <0.56) (Moore et al., 1994) and intervertebral ratios (C2-C7<0.485) (Hahn 
et al., 2008) were calculated from C2-C7 using Dicom Viewer software (eFilm 
Workstation, Merge eMed, Chicago, Illinois).  After antemortem clinical examination 
and radiographs, owner-elected euthanasia was performed with an overdose of a 
barbiturate following AVMA guidelines.  Control horses had normal neurological 
function, but were euthanized for other health-related reasons.       
MRI Evaluation 
Within 4 hours of euthanasia, the cervical spinal column was disarticulated in 
the area of T3 to T5.  Loss of cerebral spinal fluid was prevented by placing putty in 
the vertebral canal at the disarticulation site.  MR imaging was performed using a 
1.5 Tesla magnet with a flexible surface receiver coil and spinal coil.  The cervical 
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column was imaged in cranial (C2-5) and caudal (C4-C7) sections.  Sagittal, 
transverse, and dorsal plane images using multiple sequences were acquired for 
each section.  The cervical column was evaluated in the neutral position.  
Morphometric measurements were made by two independent assessors at the mid-
point of intervertebral joints for all parameters using an open source DICOM viewer 
program (Osirix, Geneva, Switzerland) (Rosset et al., 2004).  Measurements were as 
follows: spinal cord height, spinal cord width, spinal cord circumference, spinal cord 
area, vertebral canal height, vertebral canal width, vertebral canal circumference, 
vertebral canal area, left intervertebral foramen height, right intervertebral foramen 
height, and a ratio of the measured spinal cord area to vertebral canal area (Figure 
2.1). 
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Figure 2.1.  Anatomical measurements of the vertebral canal and spinal cord using 
proton density weighted MR images.  Transverse plane images demonstrate spinal 
cord and vertebral canal measurements at the midpoint of the cervical vertebral 
articulation.  A. Height and width measurements of the vertebral canal.  B. Vertebral 
canal area and circumference.  C. Spinal cord height and width measurements.  D. 
Spinal cord area and circumference 
 
Postmortem Evaluation 
Postmortem examinations were performed by two assessors.  The spinal 
cord was removed from the vertebral column during disarticulation of intact 
vertebrae.  Intervertebral sites on the spinal cord were identified and marked 
during disarticulation.  The spinal cord was placed in 10% neutral buffered formalin 
for fixation and processed routinely for histopathologic examination.  Two to four 
tissue sections were evaluated at each intervertebral site from C1-C2 to C6-C7.  
Cervical stenotic myelopathy was confirmed by identifying compressive lesions 
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microscopically at specific intervertebral sites based on the characteristic changes 
of Wallerian degeneration with presence of gitter cells, dilated myelin sheaths, 
spheroids (swollen axons), and fibrosis in appropriate dorsal, lateral, and ventral 
funiculi within the white matter (Summers et al., 1995).  Postmortem and 
histopathologic examinations were also used to rule out other infectious, 
inflammatory, or degenerative neurologic diseases of the spinal cord.   
Experimental Group Classification: 
Antemortem criteria for CSM horses included: 1) hind limb ataxia and 
proprioceptive deficits, and 2) narrowing of the cervical canal on radiographs based 
on intravertebral (C3-5 <0.50; C6 < 0.52; C7 <0.56) or intervertebral (<0.485) 
minimal sagittal ratios.  Histopathologic evidence of spinal cord compression on 
postmortem examination was the definitive parameter used for a CSM diagnosis and 
for specific site localization of disease (Table 2.1).  Inclusion criteria for control 
horses were an absence of neurologic deficits on the clinical examination and an 
absence of compressive lesions on histologic examination of the spinal cord. 
 
 Standard MSD thresholds 
for intravertebral sites, 
and intervertebral sites 
at 0.485 (radiographs) 
Intra and 
intervertebral 
thresholds at 0.485  
(radiographs) 
Histopathological 
evidence of spinal cord 
compression 
(postmortem) 
Site Controls CSM Controls CSM Controls CSM 
C2-3 1 6 0 5 0 1 
C3-4 3 16 1 12 0 13 
C4-5 2 11 1 4 0 7 
C5-6 1 16 0 10 0 11 
C6-7 5 15 3 5 0 6 
Table 2.1.  Study case categorizations based on different radiographic and 
histological thresholds and assessments.  Control (n=9) and CSM (n=19) horses 
were classified at each individual intervertebral site.  Some CSM horses were 
narrowed at multiple sites accounting for variation in numbers in the CSM category. 
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Statistical Analysis 
Vertebral canal measurements at sites of spinal cord compression as 
identified by histopathology in CSM horses were compared to control horses at the 
same cervical position.  Therefore, the total number of CSM samples analyzed at 
each vertebral site was different (Table 2.1).  Data measurements from all nine 
controls were used at each vertebral site.  Using the Anderson-Darling test, 
morphometric parameter data were normally distributed.  Data for morphometric 
parameters were analyzed using a mixed statistical model that accounted for 
variables of vertebral site, age, and gender using the PROC MIXED procedure in SAS 
(SAS, Cary, NC).  PROC LOGISTIC was used to determine if intravertebral and 
intervertebral radiographic ratios, MRI canal area, and cord canal area ratios (CCAR) 
could localize sites of histopathologic lesions on a vertebral site-by-site comparison.  
To determine whether canal area and CCAR could predict a lesion regardless of 
vertebral site, a generalized estimating equation accounting for repeated measures 
was constructed with the additional variables of age, gender, site, and set.   
Evaluation of the two MRI image assessors for concordance was done by 
calculating an intraclass correlation coefficient for each morphometric parameter.  
Coefficients, using a scale range of 0.00 to 1.00, were classified as follows:  excellent 
(>0.75), good (0.4-0.75), and poor (<0.4) (Shokuri and Edge 1996).  The intraclass 
correlation analysis was performed using the software program MedCalc for 
Windows, version 12.5 (MedCalc Software, Ostend, Belgium).  Significance was 
defined at p<0.05. 
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Results 
Identification of False Positive and False Negative Cases 
Based on the established radiographic MSD ratio and intervertebral 
thresholds with reference to histopathologic assessment of spinal cord compression, 
a subset of control and CSM horses were categorized as false positives or false 
negatives (Table 2.1).  Misclassifications based on MSD ratios were observed at each 
vertebral site and are illustrated in figure 2.2 at the level of C4-5.  Two control 
horses were classified as having vertebral canal narrowing at C4-5, while three of 
the CSM horses had vertebral canal ratios above thresholds used to indicate a 
likelihood of stenosis.  In contrast, using canal area determined from the MRI images, 
control and CSM horses segregated more distinctly (Figure 2.2).   
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Figure 2.2:  Scatter plot of the MSD ratios from radiographs and canal area 
measurements from MRI of horses with compressive lesions at C4-5.  The left 
ordinate is for the sagittal radiographic ratios with positions of the established 
thresholds indicated.  The right ordinate is for the MRI canal area data.  Two control 
horses (blue circles) have MSD ratios indicative of spinal cord compression, which 
was not present on postmortem histology.  Three CSM horses (red circles) fall above 
the radiographic thresholds, even though spinal cord compression was confirmed 
by postmortem histology.  Canal area values for two false positive control and three 
false negative CSM horses (blue and red diagonal lines respectively) cluster within 
the appropriate groups.  
 
 
Similar partitioning of CSM and control groups based on canal area and CCAR was 
observed at the other cervical vertebral sites (Figures 2.3 and 2.4). 
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Figure 2.3:  Scatter plot of the MSD ratios from radiographs and canal area 
measurements from MRI of horses with compressive lesions at the fourth, sixth, and 
seventh cervical vertebrae. 
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Figure 2.4:  Scatter plot of the MSD ratios from radiographs and cord canal area ratio 
(CCAR) from MRI of horses with compressive lesions at the fourth, fifth, sixth, and 
seventh cervical vertebrae. 
 
 
Anatomic Changes of the Cervical Vertebral Column on MRI 
While no significant differences in spinal cord measurements on MRI were 
observed, each of the vertebral canal parameters achieved significance at multiple 
sites when comparing CSM to control horses (Table 2.2).   
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Site Number Canal Height 
(cm) 
Canal Width 
(cm) 
Canal Circ. (cm) Canal Area 
(cm2) 
C2-3 Control (n=9) 2.63±0.52 2.17±0.20 8.85±1.29 5.65±1.31 
CSM (n=1) 2.56 4.432 10.096 7.419 
C3-4 Control (n=9) 2.18 ± 0.30 2.44±0.41 8.00±0.94 4.62±0.97 
CSM (n=13) 1.92±0.28**† 2.12±0.43** 6.94±.96 3.49±0.95**† 
C4-5 Control (n=9) 2.14±0.28 2.59±0.35 8.10±0.98 4.70±0.90 
CSM (n=7) 1.75±0.28** 2.26±0.41** 6.75±0.74** 3.21±0.66** 
C5-6 Control (n=9) 2.18±0.26 2.76±0.27 8.60±0.56 5.07±0.58 
CSM (n=11) 1.80±0.35** 2.51±0.59* 7.22±1.38** 3.73±1.19**† 
C6-7 Control (n=9) 2.37±0.41 3.14±0.53 9.77±01.14 6.40±1.33 
CSM (n=6) 1.85±0.46** 2.69±0.55** 8.20±1.48**† 4.38±1.52** 
 
Site Number L IV Foramen Height 
(cm) 
R IV Foramen Height 
(cm) 
Cord Area/ Canal Area 
Ratio 
C2-3 Control (n=9) 0.76±0.15 0.78±0.17 0.21±0.07 
CSM (n=1) 1.136 1.262 0.148 
C3-4 Control (n=9) 0.88±0.17 0.88±0.17 0.28±0.07 
CSM (n=13) 0.66±0.23** 0.73±0.17** 0.33±0.08**† 
C4-5 Control (n=9) 0.91±0.14 0.95±0.17 0.25±0.05 
CSM (n=7) 0.72±0.24**† 0.74±0.30* 0.37±0.08**† 
C5-6 Control (n=9) 1.05±0.11 0.98±0.17 0.26±0.03 
CSM (n=11) 0.75±0.21** 0.80±0.23** 0.36±0.09**† 
C6-7 Control (n=9) 1.18±0.18 1.20±0.23 0.25±0.05 
CSM (n=6) 0.73±0.30** 0.80±0.30**† 0.38±0.10**† 
Table 2.2:  Comparison of vertebral measurements between control and CSM horses 
on MRI.  Data are presented as the means and standard deviations.  CSM disease 
status was based on postmortem histopathologic evaluation of the spinal cord.  
*p<0.05; **p<0.01, however site C2-3 had only one CSM horse and could not be 
statistically evaluated.  † indicates significant interaction of age; 
Circ.=circumference; L IV= Left Intervertebral; R IV= Right Intervertebral 
 
The ratio of spinal cord area to vertebral canal area was larger in the CSM group, 
consistent with a decreased space within the vertebral canal for the spinal cord to 
occupy.  The intraclass correlation coefficient evaluating assessors ranged from 0.70 
to 0.89, indicating good to excellent concordance for the morphometric parameter 
assessment.  
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MRI and Radiographic Assessment for Compression 
CSM horses frequently demonstrated circumferential attenuation of cerebral 
spinal fluid on transverse images suggestive of compression (Figure 2.5). 
 
Figure 2.5:  Transverse MR images showing the absence and presence of spinal cord 
compression.  The image on the left is at the level of C4-5.  The spinal cord is round 
with circumferential cerebral spinal fluid (CSF) (green arrows).  From the same 
horse, the image on the right is at the level of C5-6 and demonstrates a narrowed 
canal area with ventral compression of the spinal cord, attenuated CSF, and 
encroachment of the articular process joints (yellow arrows).  Compression of the 
spinal cord at C5-6 was confirmed on histologic examination.  
   
Canal area and CCAR measured on MRI were evaluated for the ability to predict 
compressive lesions in a site-by-site comparison.  All vertebral sites achieved 
statistical significance with canal area and CCAR (p < 0.05) as the predictor of a 
compressive lesion at a particular vertebral site.  In contrast, for the radiographic 
parameters, lesion site significance (p <0.05) was limited to C3-4 and C5-6 for both 
intravertebral and intervertebral ratios.  The MRI canal area parameter (p <0.05) 
was able to predict compressive lesions across the entire sample set regardless of 
vertebral site.  CCAR was also significant for predicting compressive lesions. 
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Discussion 
The primary objective of this study was to compare standing cervical 
radiographs to MRI for the evaluation of cervical vertebral canal stenosis in horses.  
MRI allows examination of both soft tissue and skeletal structures in situ in multiple 
planes, which addresses the current limitation of only evaluating the sagittal plane 
when using standing radiography.  The ability to assess the cervical column in a 
transverse plane allows for the application of additional anatomic parameters and a 
more rigorous evaluation of the variability in cervical vertebral structure, which can 
cause stenosis in diseased cases.  The results indicate that MRI is superior as an 
imaging tool for the identification of vertebral canal narrowing in horses with CSM 
when compared to standing cervical radiographs.  This finding is consistent with the 
results of a study that examined the use of MRI to assess canine cervical vertebral 
pathology.  Comparison of myelography and MRI techniques in Doberman Pinchers 
found that MRI had a higher degree of accuracy for identifying the site and severity 
of spinal cord compression (da Costa et al., 2006).  In the current study, spinal cord 
compression of CSM horses frequently demonstrated circumferential attenuation of 
cerebral spinal fluid on transverse images (Figure 2.5).  Significant differences were 
seen in anatomical measurements of the vertebral canal (Table 2.2), but not the 
spinal cord itself.  This finding is consistent with a pathogenesis that starts with 
skeletal malformations resulting in compression of the cervical spinal cord (Stewart 
et al., 1991; Mayhew, 1978). 
Interestingly, multiple control horses had at least one area with radiographic 
measurements suggestive of cervical spinal canal narrowing on standing lateral 
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views, yet no neurological deficits on clinical examination or histopathologic 
evidence of spinal cord compression.  Figure 2.2 is a graphic comparison of the 
corresponding canal areas and standard MSD intravertebral ratios for all horses in 
the study with compressive lesions at C4-5 and the controls.  Using either the 
standard MSD or 0.485 thresholds for cervical radiography at intravertebral and 
intervertebral sites, two controls fall below these lines and are false positives given 
their absence of compressive lesions on histology.  In addition, three horses with 
cord compression confirmed by histology have values above these thresholds, 
making them false negatives on radiographs.  Canal area measurements obtained 
from MR images at the same sites, however, segregate more accurately.  As a two-
dimensional transverse measurement, canal area accounts for variability not only in 
canal height but other directions as well.  Sagittal plane views on lateral cervical 
radiographs are limited to assessment of canal height in the dorsal-ventral direction 
only.  Variation in vertebral canal shape may provide adequate room for the spinal 
cord despite a low canal height.  This is a possible explanation for the subset of 
horses with a suggestion of compression on lateral radiographs, yet an absence of 
clinical or pathologic lesions consistent with CSM.  While some ambiguity remains, 
as represented by an overlap of canal area and CCAR measurements between CSM 
and control horses at various vertebral sites (Figures 2.3 and 2.4), the results of this 
dataset indicate an improvement over lateral cervical radiographs. 
Neck position is an additional opportunity for improving the accuracy of 
diagnostic imaging.  Myelograms have been used to demonstrate how cord 
compression can be accentuated in flexion or extension in some cases (Nixon et al., 
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1982).  This has lead to a description of lesions as dynamic if flexion or extension 
accentuates the compression, or static if compression is evident regardless of neck 
position.  Dynamic lesions might also explain the apparent paradox of cord canal 
area ratios being less than one at sites of compression in CSM horses.  While the 
mean values are significantly higher than the controls, measurements ranging from 
0.33 – 0.38 cm2 still suggest adequate space for the spinal cord within the vertebral 
canal.  However, if the compression is position-dependent, then the true severity of 
the stenosis may not be reflected in the CCAR with the neck in a neutral position.  
There are also varying degrees in the severity of stenosis, and therefore the average 
CCAR for the sample set does not reflect the gradient of stenosis observed in 
individual cases.  
Intervertebral foramen heights varied at different vertebral sites, but were 
consistently smaller in CSM horses.  This finding supports previous work in which 
CSM horses were examined by computed tomography (CT) with lateral compression 
of cervical spinal nerve roots due to malformations in the articular processes 
(Moore et al., 1992).  In this study as well, altered position of the articular processes 
impacted intervertebral foramen height.  Identification of significant differences 
between CSM and control groups in regards to intervertebral foramen heights is 
largely dependent on the spatial positioning and size of the articular processes. 
As discussed above, the determination of canal area is a more accurate 
assessment of canal size, but the ability to predict compressive lesions is the 
important diagnostic issue.  In contrast to intervertebral and intravertebral sagittal 
ratios, canal area and CCAR were able to predict histopathologic compressive 
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lesions regardless of vertebral site.  Overall, vertebral canal area was smaller at sites 
of compression identified by histologic examination as compared to the controls.  In 
the exceptions, where CSM canal areas segregated with canal area of controls, it is 
felt this is largely due to the limitations of only the neutral position being evaluated 
in this study.  Therefore, in the future, canal area and CCAR could be developed as 
morphometric parameters for antemortem assessment of Wobbler Syndrome in the 
horse.    
 Age was found to have an influence on several morphometric parameters in 
this study (Table 2.2).  The growth plates of the vertebral endplates in the cervical 
column do not close until 4-5 years of age.  Horses included in the sample set were 
up to 5.5 years of age; therefore, there is continued maturation of the vertebrae as 
the result of normal growth patterns in the horse.  These findings reflect the young 
age of onset often seen in the development of CSM.   
The current study was performed with a sample set of 19 CSM horses and 9 
controls, yet was still able to detect significant differences between the two groups 
of horses.  Examination of more horses in future studies will provide additional 
power for the establishment of threshold MRI criteria to predict the presence or 
absence of stenosis, as is currently defined for the assessment of standing cervical 
radiographs with the intravertebral and intervertebral minimal sagittal diameter 
ratios.  With an increased sample size, a receiver operating characteristic (ROC) 
curve could be constructed for assessment of diagnostic accuracy and determination 
of the sensitivity and specificity of the canal area parameter.  Given the significance 
of canal area and CCAR to identify specific sites of compression on postmortem MRI, 
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it is felt these parameters could possibly provide an increased sensitivity and 
specificity for identifying canal stenosis antemortem.  This could have a strong 
impact on site selection for cases undergoing review for surgical treatment.  Further 
investigation of the vertebral canal area and CCAR is necessary in regards to the 
influence of position and establishment of intervertebral site-specific thresholds.  
However, breed differences are likely to be important (Mitchell et al., 2012).  All 
horses evaluated in the current sample set, both cases and controls, were 
Thoroughbreds with an age range of 6 months to 5.5 years.  Absence of breed 
variation likely contributed to the finding that canal area could accurately predicted 
lesion site, in contrast to the earlier study.  For this reason, CCAR or another ratio 
parameter may prove to better accommodate breed and age variations than the 
absolute measure of vertebral canal area.    
Technology is continuing to advance in regards to both MRI and CT units.  
Although the size of most adult equine patients currently precludes antemortem 
assessment of the complete cervical column by MRI, large bore CT scanners may 
permit imaging of the entire equine cervical vertebral column.  It is feasible that 
transverse plane vertebral column measurements could be obtained in this fashion 
for clinical cases.  The ability to image the cervical vertebral column in the 
transverse plane and multiple neck positions will substantially enhance clinical 
evaluation of CSM horses.   
 
 
Copyright © Jennifer Gail Janes 2014 
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Chapter 3 
 
Skeletal Pathology Of The Cervical Articular Processes In Equine 
Cervical Stenotic Myelopathy 
Summary 
Skeletal lesions in the articular processes of cervical vertebrae C2 – C7 were 
compared between horses with cervical stenotic myelopathy (CSM n=19) and 
controls (n=9).  Lesions identified by magnetic resonance imaging (MRI) occurred 
with an increased frequency and severity in CSM horses and were not limited to the 
site of compression.  Pathology involved both the articular cartilage and trabecular 
bone, including osteochondrosis, osseous cyst-like structures, fibrous tissue 
replacement of trabecular bone, and osteosclerosis.  The identification of osseous 
cyst-like structures is a novel finding.  These lesions and their generalized 
distribution indicate that developmental abnormalities of the cervical spine are 
primary changes associated with equine CSM. 
Introduction 
 Equine CSM is a multifactorial disease of the musculoskeletal system that 
presents clinically with proprioceptive neurologic deficits that are worse in the 
pelvic limbs.  The disease is characterized by malformations of one or more cervical 
vertebrae that lead to stenosis of the spinal canal, cord compression, and damage to 
nerve tracts.  Proposed etiologic factors include high planes of nutrition, accelerated 
growth rates, altered ratios of copper and zinc, and inherited genetic determinants.  
While much is known regarding signalment and clinical diagnosis, the exact 
pathogenesis of CSM remains unclear and likely reflects more than one path to a 
similar clinical presentation.  Over the years, two theories have been proposed 
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based on multiple studies.  The developmental theory proposes an underlying 
disorder of bone and cartilage tissue morphogenesis and maturation leading to 
cervical vertebral malformations.  The biomechanical theory, in contrast, advances a 
process whereby abnormal mechanical stresses and forces on the cervical column 
result in structural vertebral changes leading to canal stenosis. 
 Efforts put forth by multiple groups have contributed to a knowledge base 
for aberrations in vertebral development associated with CSM.  A comprehensive 
examination of pathologic lesions (Mayhew et al., 1978) suggested abnormal bone 
and cartilage maturation manifested as osteosclerosis and osteochondrosis.  
Interestingly, lesions were also observed in the costochondral junction of the ribs 
supporting a possible systemic bone and cartilage maturation issue.  Further work 
examined the frequency and severity of osteochondrosis in the articular processes 
with comparison to the appendicular skeleton (Stewart et al., 1991), finding an 
increased severity of osteochondritic lesions in both the axial and appendicular 
skeleton of CSM horses.  It has also been suggested that cervical malformations 
could start as early as in utero (Mayhew, 1999). 
 On the other hand, there is support for a model of pathogenesis whereby 
abnormal biomechanical forces lead to vertebral malformations and canal stenosis.  
Maturation of equine vertebrae continues until approximately 5 years of age at 
which point the vertebral body growth plates close (Whitwell and Dyson, 1987).  
During this time and even following growth cessation, vertebrae are responsive to 
biomechanical forces on the neck through Wolff’s Law and related variables of 
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mechanical regulation (Wolff, 1986; Chen et al., 2010).  Mechanical variables in the 
form of strain, oscillation, and vibrations have been demonstrated to impact bone 
morphology (Judex et al., 2009).  Lesions consistent with abnormal forces on the 
neck include degenerative changes of the articular processes, thickening of the 
dorsal lamina, and hypertrophy of the ligamentum flavum (Powers et al., 1986; 
Trostle et al., 1993).   
 The major knowledge gap(s) in regards to CSM pathogenesis is/are the 
mechanism(s) by which these lesions develop and progress to clinically significant 
spinal canal stenosis.  The rapid development of imaging technologies allows for 
examination of the cervical column in situ for pathologic lesions associated with 
CSM.  This study focuses on the articular processes, given that changes in their 
shape, size, and spatial orientation frequently contributes to spinal cord 
compression (Moore et al., 1992). 
Experiments in this chapter aim to assess, both quantitatively and 
qualitatively, cartilage and bone lesions observed by MRI in the articular processes 
of CSM horses as compared to controls.  A subset of representative lesions is then 
further characterized with micro-CT and routine histopathology.  Achieving a better 
understanding of the distribution and types of lesions that occur within the articular 
processes will lead to greater insight into the etiopathogenesis of CSM in the horse. 
 
 
 
 
 
49 
Materials and Methods 
Magnetic Resonance Imaging  
Sample Acquisition 
 Horses identified for these experiments follow the criteria previously 
outlined in chapter 2 of this thesis.  Briefly, CSM horses (n=19) underwent 
neurologic examinations and standing cervical radiographs.  Postmortem, gross and 
microscopic evaluation of the spinal cord was performed.  Presence of a focal 
compressive lesion was used as the criteria to confirm CSM and specific site 
localization.  All control horses (n=9) had an absence of clinical and postmortem 
characteristics consistent with neurologic disease.  Acquisition of MRI data from the 
cervical column was performed within 4 hours of euthanasia.  T2, PSFD, and STIR 
images were obtained.  Immediately following MRI, each vertebrae was 
disarticulated intact from the cervical column and placed in 10% neutral buffered 
formalin for fixation. 
Articular Process Lesion Identification, Location Classification, and Severity Scale 
 Variations from expected MRI signal intensity were identified as perspective 
lesions and classified as either superficial or deep based on anatomic location.  
Superficial lesions involved the articular cartilage and/or subchondral bone with 
possible extension into the trabecular bone.  Lesions within an articular process that 
did not involve the articular cartilage or subchondral bone were defined as deep.  
Lesions were then assigned a grade of 0-3 based on a scale adapted from previous 
work (Smith et al., 2012) and described below (Figure 3.1).  Lesions were required 
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to be present on a minimum of 2 of the 3 MRI image studies (PDFS, T2, STIR). 
 
Figure 3.1:  Summary of the superficial and deep lesion criteria and corresponding 
severity grading scale. 
 
Statistical Analysis 
A generalized linear statistical model was used to determine if there were 
significant differences in frequency of articular process lesions between CSM and 
control groups.  In this model, lesion count was regressed on group using the 
Poisson regression (SAS, Cary, NC).  For assessment of severity, a generalized linear 
equation with a multinomial model to account for the grading scale of 0-3 was used.  
Significance was defined as p <0.05. 
 
 
Superficial lesion scoring criteria:  Involvement of the articular cartilage and/or the subchondral 
bone and possible extension into the underlying trabecular bone. 
Grade 0:  Normal (no pathology detected) 
Grade 1:  Subtle irregularity of chondro-osseous margin with no involvement of 
subchondral bone 
Grade 2:  Irregular chondro-osseous margin with subchondral bone defect of < 0.7cm in 
either dimension 
Grade 3:  Irregular chondro-osseous margin with subchondral bone defect of > 0.7cm in 
either dimension 
 
Deep lesion scoring criteria:  Trabecular bone involvement with no involvement of the articular 
cartilage or subchondral bone. 
Grade 0:  Normal (no pathology detected) 
Grade 1:  Generalized mild signal alterations 
Grade 2:  Generalized moderate signal alteration or focal signal intensity changes < 1 cm 
in any dimension 
Grade 3:  Generalized severe signal alterations or focal signal intensity changes > 1 cm in 
any dimension 
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Structural Analyses of Articular Process Lesions 
Sample Identification 
 A subset of samples from the above-described dataset was selected for 
structural analyses.  Four CSM horses with deep lesions and four CSM horses with 
superficial lesions were chosen (Table 3.1).  Control horses with an absence of 
lesions on MRI were identified to match as best as possible for anatomical site, 
gender, and age of the CSM horses.  No horse was repeated within or across groups.  
Articular process sites varied between groups.  All lesions were assessed as a grade 
2 or grade 3.  Articular processes both at and away from the site of spinal cord 
compression were included.  The table below summarizes the signalment of the 
groups.  Articular processes were removed from the vertebrae for scanning. 
Deep Lesions 
 CSM (n=4) Control (n=4) 
Site Age Gender Age Gender 
Left caudal C5 11 months Male 17 months Male 
Left cranial C6 6 months Male 10 months Male 
Right cranial C6 13 months Male 15 months Male 
Right cranial C7 18 months Male 23 months  Male 
 
Superficial Lesions 
 CSM (n=4)  Control (n=4) 
Site Age Gender Age Gender 
Left caudal C2 15 months Male 17 months Male 
Left cranial C4 20 months Male 22 months Female 
Left caudal C6 10 months Female 9 months Female 
Left cranial C7 50 months Female 67 months Female 
Table 3.1:  Signalment and articular process sites for structural analysis. 
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Micro-CT Image Acquisition and Visualization 
 A custom micro-CT scanner (150/225 Ffi-HR-CT, BIR, Lincolnshire, IL) with a 
225kV X-ray source, 5μm focal spot, and image intensifier with a 1024 x 1024 pixel 
digital camera was used.  X-ray power settings were 135 KeV and 0.059 mA with a 
distance of 703 mm from the x-ray source to the image detector (Voor et al., 2008).  
The source to object distance was 177.5 mm.  Scanning was performed in the offset 
mode with the center of the tube 15 mm lateral to the center of the x-ray beam.  The 
articular process was placed in a radiolucent acrylic holder and scanned using a 360 
degree-plus-fan-angle rotation.  A total of 107 slices were captured per revolution 
with each slice representing a thickness of 30 μm.  The final reconstruction resulted 
in image stacks of 2048 x 2048 pixels.  Image stacks contained 30 μm voxels with a 
16 bit gray scale..  
 Image stacks were imported into VGStudio Max for construction of 3D 
models of the articular processes (v1.2.1, Volume Graphics, Heidelberg, Germany).  
Regions of interest were identified based on localization from MRI data 
demonstrating the lesions.  The cranial or caudal most point of the articular margin 
was identified on MR and used as the starting point for measurements to localize the 
lesion.   
Trabecular Bone Volume Measurement 
 Images stacks of 200 slice increments were imported into Image J (Abramoff 
et al., 2004) at 25% of the total image size.  Coordinates were acquired for image 
stack borders for trabecular bone volume measurements in a custom bone volume 
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analysis program using MATLAB (v7.1, The Mathworks, Natick, MA).  Trabecular 
bone volume was calculated as percentage of total volume. 
Statistical Analysis 
A generalized linear model was used to determine if there were significant 
differences in trabecular bone volume of the articular processes identified in CSM 
horses with deep lesions compared to controls, CSM horses with superficial lesions 
compared to controls, and then a combination of the deep and superficial groups 
compared to controls (SAS, Cary, NC).  Significance was defined as p <0.05. 
Histopathologic Assessment of Articular Process Lesions  
Sample Identification 
 A representative subset of articular process lesions identified on MRI from 
both CSM and control horses were assessed histologically.  All lesions imaged with 
micro-CT were included in this study.  The figure below summarizes the sample 
numbers and distribution of grades within each group (Figure 3.2).  No horses were 
repeated within a grade or a group, although in some cases independent lesions 
from the same horse were used across groups.  
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Figure 3.2:  Number of samples in each grade category analyzed histologically.  
Grades are variable within the mixed group, as often the superficial and deep 
components would qualify for different grades based on severity.  Control horses 
had a very limited number of deep lesions available for assessment. 
 
Histopathologic Processing and Evaluation 
 Transverse sections of the region of interest from the articular processes 
were excised using a scroll saw based on MRI localization and measurements.  
Sections were decalcified using Decalcifier Rapid S (Labsco), embedded in paraffin, 
and 5 μm sections processed routinely for hematoxylin and eosin staining.  Slides 
were examined for histopathologic changes. 
 
Results 
MRI Lesion Frequency 
 Lesions identified on MRI studies were evaluated for significant differences 
in frequency between CSM and control horses.  Analyses compared anatomic 
localization (superficial or deep), compression site or noncompression site, as well 
as the entire cervical column.  Significant differences were identified on frequency 
comparisons using all lesions at all sites, all superficial lesions, all deep lesions, and 
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deep lesions at noncompression sites (Figure 3.3).  Within the group of CSM horses, 
there were individuals with compression and others without compression at each 
vertebral site.  Therefore, the corresponding control dataset used for comparison 
are the same within All Lesion, Superficial Lesion, and Deep Lesion categories.  
 
Figure 3.3:  Articular process lesion frequency distribution.  Compression and 
noncompression designations refer to anatomical locations of stenosis for the CSM 
horses, with comparison to the corresponding anatomical sites from control horses.  
By definition, control horses have no cervical spinal cord compression sites.  Data 
are represented as average number of lesions per horse in each group.  * p value 
<0.01.   
 
Lesion Severity Analysis 
 In addition to the number of articular process lesions, severity of the lesions 
was assessed between CSM and control horses.  The same categories of anatomic 
location of the lesion within the articular process as well as location in the cervical 
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column with respect to compression were analyzed.  Significance was observed in 
all comparisons except for superficial lesions at noncompression sites.  Distribution 
of lesion grade for all comparisons is shown below (Figure 3.4). 
 
Figure 3.4:  Articular process lesion severity distribution.  Data are presented as the 
percent of the total number of lesions for each grading category.  Severity 
distribution patterns were significantly shifted to greater severity in CSM horses in 
all categories except for superficial lesions at noncompression sites.  Blue bars 
represent the control group and red bars represent the CSM group. * p value < 0.05; 
** p value < 0.01  
 
Microarchitectural Bone Volume Assessment 
 A subset of lesions identified on MRI was imaged using micro-CT for 
assessment of trabecular bone volume and an evaluation of trabecular bone 
architecture.  No significant differences in trabecular bone volume were found 
(p>0.05) when comparing the articular processes with superficial lesions to controls, 
 
 
57 
articular processes with deep lesions to controls, or combination of the two groups 
(Table 3.2). 
Lesion Categorization Sample Groups p-value 
Deep Lesion CSM (n=4) Control (n=4)  
Trabecular Bone Volume 0.3885 ±0.04 0.3431±0.02 0.087 
Superficial Lesion CSM (n=4) Control (n=4)  
Trabecular Bone Volume 0.3591±0.02 0.3495±0.03 0.500 
All Articular Processes CSM (n=8) Control (n=8)  
Trabecular Bone Volume 0.3738±0.03 0.3463±0.02 0.059 
 
Table 3.2:  Trabecular bone volume comparisons in articular processes.  Data are 
represented as the percentage of total volume occupied by trabecular bone based on 
micro-CT analyses.  Averages and standard deviations for each group are listed.  No 
significant differences between control and CSM horses were identified.   
 
Analyses of deep lesions on micro-CT demonstrated that they were not 
composed of bone (Figure 3.5).  This finding was observed in all 4 articular 
processes analyzed in the deep lesion group.  An absence of bone was also observed 
for superficial lesions in the four articular processes examined, including when 
there was extension of the lesion into the subchondral region (Figure 3.6).  In 
contrast, perilesional regions often, but not always, exhibited trabecular thickening 
consistent with areas of bone sclerosis (Figures 3.5 and 3.6).  
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Figure 3.5:  Micro-CT and MRI of a deep lesion within the articular process.  This is 
the left cranial articular process from C7 of a CSM horse.  The left image is a 3D 
model generated by micro-CT showing a deep lesion in cross section.  A discrete 
focus with absence of trabecular bone structure is observed (green arrow).   On the 
right, the MR image is localized to the same level as the 3D model.  A focal signal 
increase within the trabecular bone is seen (yellow arrow).  The difference in 
resolution between the imaging modalities accounts for the size discrepancy of the 
lesion in each of these images. 
 
            
 
Figure 3.6: Micro-CT and MRI of a superficial lesion within the articular process.  
This is the left cranial articular process from C4 of a CSM horse with a grade 2 lesion 
identified on MRI.  The left image is a 3D model of the articular process in cross 
section.  At the green arrow is an invagination into the subchondral bone that is not 
composed of bone.  Adjacent to the invagination, the trabecular bone is markedly 
thickened (sclerosis).  On the right is the corresponding localization of the lesion on 
MRI.  There is a focal signal increase that extends from the articular surface into the 
subchondral bone (yellow arrow). Also, there is an adjacent decrease in signal 
indicating bone sclerosis consistent with the thickened trabecular bone observed on 
micro-CT.   
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Histopathologic Assessments 
 All superficial lesions identified in CSM and control horses were consistent 
with varying degrees of osteochondrosis.  Both osteochondrosis manifesta (OM) and 
osteochondritis dissecans (OCD) were observed (Figure 3.7 and 3.8).  Since the 
lesion grading categories were based on size, both OM and OCD were seen in grade 
2 and grade 3 categories.  Associated with the cartilaginous defects was a moderate 
to severe thickening and remodeling of the subchondral bone, which extended 
variably into the trabecular bone of the articular process. 
 
Figure 3.7:  Osteochondrosis manifesta lesion (grade 3) image series.  On the left is a 
gross image of the articular defect (arrow) identified on left caudal C6 of a CSM 
horse.  The middle image is the same lesion on MRI.  The arrow indicates an 
irregular chondro-osseous margin with an adjacent increase in signal intensity.  On 
the right, is a photomicrograph of the same lesion at 2X magnification.  There is a 
focal area of cartilage necrosis (arrows) surrounded by thickened subchondral bone.   
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Figure 3.8:  Osteochondritis dissecans lesion (grade 3) image series.  On the left is a 
gross image of the articular defect (arrow) identified on the left caudal articular 
process from C2 of a CSM horse.  The middle image is the same lesion on MRI 
(arrow) composed of a slightly irregular chondro-osseous margin with an increase 
in signal intensity extending into the bone.  On the right is a photomicrograph at 2X 
magnification.  The arrow indicated the separation of the articular cartilage from the 
bone consistent with OCD.  
 
Deep only lesions in CSM horses were composed of cyst-like structures 
within the trabecular bone, fibrous tissue replacement of trabecular bone, and 
retention of variably size foci of cartilaginous matrix deep in the trabeculae (Figure 
3.9).  Cells lining the lumen of the cyst-like structures were negative for cytokeratin, 
a marker for epithelium.  Cyst-like structures were surrounded by organized fibrous 
connective tissue.  The two deep lesions identified in control horses were both 
retention of small to moderate amounts of cartilaginous matrix within the 
trabecular bone.  No cyst-like lesions in the articular processes of control horses 
were observed. 
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Figure 3.9:  Image series of cyst-like structures in deep articular process lesions of 
CSM horses.  Image A shows a cyst-like structure in the trabecular bone at 2X 
magnification.  Higher magnification (10X) of the same structure is seen in figure B.  
The cyst-like structure is composed of a surrounding fibrous stroma with no 
discernable epithelial lining.  Image C shows a different cyst-like structure (green 
arrow) at 4X magnification surrounded by trabecular bone sclerosis (asterisk).  The 
cells lining the cyst-like structure are shown at 40X magnification in figure D (green 
arrow).   
 
Mixed lesions were composed of a variety of pathologies.  Consistent with the 
superficial only lesions, the superficial component of the mixed lesions fell under 
the spectrum of osteochondrosis.  The deep lesions away from the articular surface 
were composed of areas of fibrous replacement of trabecular bone with active bone 
A 
D C 
B 
* 
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remodeling, cyst-like structures, occupation of the marrow cavity with varying 
amounts of fibrous connective tissue, and mature venous sinuses within the marrow 
space (Figure 3.10).    
        
Figure 3.10:  Histopathology photomicrographs of the deep lesions in the mixed 
category.  Figure A shows normal trabecular bone (yellow arrow) and marrow space 
(green arrow) at 2X magnification.  Replacement of trabecular bone with dense 
streams and bundles of fibrous connective tissue (*) is shown in figure B at 10X 
magnification.  On the bottom left in figure C, organized prominent venous sinuses 
occupy the marrow space with paucity of normal marrow elements at 20X 
magnification.  Loosely organized fibrous connective tissue replacing hematopoietic 
elements in the marrow space is shown in figure D at 10X magnification. 
     
 
Discussion 
 The objective of these experiments was to evaluate and compare the 
frequency and severity of skeletal lesions in articular processes of cervical vertebrae 
B A 
C D 
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identified on MRI between CSM and control horses.  A representative subset of these 
lesions was further characterized using micro-CT and routine histopathology.  
Lesion frequency, location, and severity analyses examined the cervical column as a 
whole, at the site of cord compression, and away from the site of compression.  
While lesions were observed in both control and CSM horses, frequency and 
severity were significantly increased in the CSM group.  Lesion frequency was 
higher in the CSM horses across the entire cervical column for both superficial and 
deep lesions, as well as for deep lesions at noncompression sites.  In addition, 
identified lesions had an increased severity in the CSM horses.  These data support 
previous work that concluded pathology in the neck of CSM horses is generalized 
and not limited to the site of compression (Stewart et al., 1991).   
A variety of lesions were observed on histopathology of the articular 
processes.  All superficial lesions identified on MRI that were further evaluated 
using histopathology fell under the continuum of osteochondrosis (OC).  OC is a 
developmental disease that results from localized failure of endochondral 
ossification.  Recently, efforts to improve nomenclature for OC has resulted in 3 
categorizations, osteochondrosis latens, osteochondrosis manifesta, and 
osteochondritis dissecans  (Ytrehus et al., 2007).  Osteochondrosis latens is a focal 
area of cartilage necrosis within the epiphyseal cartilage.  When cartilage necrosis 
extends into the adjacent subchondral bone it is classified as osteochondrosis 
manifesta.  The most severe manifestation, osteochondritis dissecans, occurs when 
the integrity between the cartilage and bone is lost and a flap or loose body of 
cartilage is released.  Osteochondrosis manifesta lesions were observed in control 
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and CSM horses whereas OCD was only seen in CSM horses.  The presence of OCD in 
CSM horses is supportive of the increased severity distribution in CSM pathology.  
On micro-CT, the four OC lesions evaluated had loss of bone structure consistent 
with the retention of cartilage through failure of endochondral ossification.  
Osteochondrosis in the cervical column of CSM horses has been reported previously 
(Stewart et al., 1991; Mayhew, 1978).  Findings in this study further substantiate the 
association of OC with CSM.   
Deep lesions on MRI displayed a variety of histopathological changes.  An 
interesting finding was the presence cyst-like structures within the trabecular bone 
away from the articular surface in the CSM horses.  This is the first report of these 
lesions in the articular processes of CSM horses.  On micro-CT, all 4 articular 
processes with deep lesions were visualized as focal areas with an absence of 
trabecular bone structure (Figure 3.5).  Histopathology confirmed that 3 of the 4 
deep lesions analyzed using micro-CT were cyst-like structures composed of an 
empty lumen surrounded by organized fibrous connective tissue.  Classically, bone 
cysts are characterized as simple, subchondral, or aneurysmal (Carlson and 
Weisbrode, 2012).  Simple cysts are lined by fibrous tissue and contain clear to 
serosangiunous fluid.  Remodeling of the bone adjacent to the cyst can be a feature 
as well.  Cyst-like structures observed in the articular processes fit best with the 
simple categorization.  The exact cause of simple bone cysts is unknown.  Suspected 
causes include vascular malformations, hemorrhage, ischemic necrosis, occlusion of 
venous drainage, or developmental abnormalities (Carlson and Weisbrode, 2012; 
Chigira et al., 1983; Khurana JS, 2009).   
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The identification of these cyst-like structures generates the following 
question:  are these structures related to osteochondrosis in some fashion?  As 
noted earlier, OC is a developmental problem of endochondral ossification 
impacting bone and cartilage in diarthrodial joints.  Subchondral bone cysts 
adjacent to the articular cartilage have been described with OC.  It is unknown at 
this time if the cyst-like structures in the current study were another manifestation 
of OC or independent.  Their localization was frequently deep in the trabecular bone 
away from the articular cartilage-subchondral bone interface, which could be a 
confounder for a direct relationship with OC. 
While the identification of the cyst-like structures is novel in the articular 
processes, there are previous reports of this pathology in other bones of the horse.  
Osseous cyst-like lesions have been reported in the appendicular joints of horses, 
specifically the fetlock joint, carpal joint, tarsus joint, navicular bone, and phalanges 
(Murray et al., 2011; Anastasiou et al., 2003).  The presence of these lesions is often 
associated with trauma, but can also be related to developmental factors.  Clinical 
significance of these lesions in the appendicular joints can be either incidental or 
pathologic.  If the surrounding bone is normal, then cyst-like lesions are usually 
interpreted as incidental.  In cases where adjacent sclerosis is observed, cyst-like 
lesions are considered pathologic (Powell, 2011; Murray et al., 2011).  Using these 
criteria, both incidental and pathologic cyst-like structures were observed in the 
CSM horses.  
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 Several other interesting lesions were observed in individual cases.  In 
articular processes from a 6 month old colt with CSM, well-defined, prominent 
venous sinuses were observed scattered in the marrow space both adjacent to the 
articular surface near OC lesions and deep in the trabecular bone (Figure 3.10).  
Hematopoietic elements in these areas were rare.  Given the fluid nature of blood, 
the lesions were visualized as multifocal pinpoint increases in signal intensity on 
MRI.  Their significance is unclear.  
 Another interesting lesion observed in several cases was varying degrees of 
fibrous replacement of marrow elements and trabecular bone often surrounded by 
marked bone remodeling (Figure 3.10).  This fibrosis was observed near OC lesions 
and in the trabecular bone without communication to the articular surface.  The 
remodeling bone was characterized by haphazardly arranged trabeculae lined by 
osteoblasts (woven bone), and scalloped basophilic cement lines indicative of active 
bone resorption and replacement.  These foci of fibrous connective tissue and 
collagen surrounded by bone remodeling could represent sites of previous injury 
that are in the process of stabilization and repair.  Foci closer to the articular surface 
could be a response to adjacent chronic OC lesions.  The cause of the fibrous foci 
deeper in the trabecular bone is unknown, but interesting nonetheless.  One 
possibility is the deeper lesions could be previous cyst-like structures that collapsed 
and are now in a healing process.  Identification of the original cause of these fibrous 
lesions may help clarify contributing steps in the pathogenesis of CSM.  
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 Previous studies have described trabecular bone sclerosis in the dorsal 
lamina and vertebral body endplates of vertebrae in CSM horses (Mayhew, 1978; 
Powers et al., 1986; Trostle et al., 1993).  Bone sclerosis can develop due to impaired 
function of osteoclasts and osteoblasts, as well as metabolic signals that affect 
normal remodeling and resorption.  However, osteosclerosis can also occur as a 
compensatory response to increased mechanical stress with suppression of bone 
resorption resulting in an increase of bone mass as described in Wolff’s law.  When 
occurring in response to biomechanical forces, areas of osteosclerosis contain 
normal sized lacunae (Powers et al., 1986; Trotter et al., 1976; Wright et al., 1973; 
Parfitt, 1977).  This was observed for the sclerotic regions of subchondral and 
trabecular bone in the current study, implicating biomechanical forces as the cause 
versus an impairment of normal bone turnover from cellular or hormonal 
mechanisms.   
Given previous reports and the observations in the current study of 
osteosclerosis in the articular processes, the trabecular bone volume of the entire 
articular process in CSM and control horses was evaluated.  Although mean 
trabecular bone volumes were numerically greater in CSM horses in each category 
(Table 3.2), the differences were not significant.  Combining samples from the 
superficial and deep lesion groups yielded a p value of 0.051.  Given the extent of 
trabecular bone thickening perceived in the superficial, deep, and mixed lesions 
during histopathologic examination, it is possible that with an increase in sample 
size, significant trabecular bone volume differences would be detected.  Analyses of 
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bone volume in lesion areas relative to areas distant from any lesions identified on 
MRI would also be interesting. 
 Other comparisons that were not significant included the frequency of 
superficial lesions regardless of site, frequency of superficial lesions at 
noncompression sites, and the severity of superficial lesions at noncompression 
sites.  A possible explanation is that all superficial lesions in this study were 
identified as some form of osteochondrosis.  Prevalence of osteochondrosis in the 
Thoroughbred is estimated at ~25% (Lepeule et al. 2009) and has been documented 
in the cervical column of horses previously (Stewart et al., 1991 and Mayhew, 1978).  
The prevalence of osteochondrosis in general and its observation in both control 
and CSM horses in this study may explain the lack of significance in several of the 
superficial lesion comparisons. 
MRI studies permit cervical column evaluation in situ allowing for a more 
complete identification and assessment of articular process pathology associated 
with CSM.  Consistent with a previous report, pathology was not localized to only 
compression sites, but observed throughout the cervical column (Stewart et al, 
1991).  These findings support a generalized issue of bone and cartilage in the 
cervical column.  The focus of this study was pathology of the articular processes.  It 
would be useful to investigate if similar bone and cartilage lesions are observed in 
other parts of the vertebrae, as well as in the appendicular skeleton.   
The new data reported provide further evidence that developmental 
aberrations of cervical vertebrae morphogenesis is important in the pathogenesis of 
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equine CSM, manifested as both osteochondrosis and cyst-like-lesions.  In contrast, 
osteosclerosis may reflect a compensatory response in still maturing CSM horses to 
abnormal biomechanical stresses on the cervical column.  Therefore, both 
developmental and biomechanical mechanisms may lead to the bone and cartilage 
changes observed in CSM.  A model where biomechanical changes are secondary to 
primary developmental issues seems more likely.  The intersection of 
developmental and biomechanical influences in the growing horse sets the stage for 
a complex interaction of variables.  Future studies focusing on associations of CSM 
etiologic factors (high planes of nutrition, abnormal growth rates, abnormal copper 
and zinc levels, inherited genetic determinants) with specific bone and cartilage 
pathology in cervical vertebrae will help further elucidate the pathogenesis of 
equine CSM.   
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Chapter 4 
The Role Of Inherited Genetic Determinants In Equine Cervical Stenotic 
Myelopathy 
Summary 
Experiments in this chapter tested the hypothesis that inherited genetic 
determinants contribute to the susceptibility of equine cervical stenotic myelopathy 
(CSM).  Single nucleotide polymorphism (SNP) allele frequencies in the genomic 
DNA (gDNA) of carefully phenotyped CSM horses (n=59) were compared to 
population data (n=427) using the Equine SNP50 and Equine SNP70 Bead Chips for 
a genome wide association study (GWAS).  Results of the GWAS identified multiple 
significant loci, both individual SNPs and haplotypes, across the genome.  An 
additional association analysis was conducted by comparing the inheritance of 
genomic copy number variants (CNVs) across 8 individuals in a single family with a 
high incidence of the disease.  The data support a genetic contribution to the 
etiology and/or pathogenesis of CSM, with inheritance likely complex in nature 
involving multiple gene loci.  Results are consistent with the understanding that 
CSM is influenced by both genetic and environmental variables.   
Introduction 
 Cervical stenotic myelopathy (CSM) results from malformations in the 
cervical vertebrae, which leads to vertebral canal stenosis and spinal cord 
compression.  The condition is thought to be multifactorial, with both 
environmental and genetic variables contributing to etiology and pathogenesis.  
Known environmental factors include accelerated growth rates, high planes of 
nutrition, and altered copper and zinc concentrations.  The importance of heritable 
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genetic determinants in regards to equine CSM has been studied by several groups, 
but remains an unresolved and debated issue. 
An initial published investigation for the role of genetic determinants came 
from a multigenerational pedigree analysis looking at 6 Thoroughbred families 
(Dimock, 1950).  Sire lines were examined and concluded that 43% of CSM progeny 
in the pedigrees traced to one of the three Thoroughbred foundation sire lines.  A 
possible recessive inheritance, but not simple autosomal recessive was suggested 
from this work.  Additional support for a possible recessive mode of inheritance 
came from a German investigator (Weischer, 1944; Weischer, 1946), based on 
observations.  Previous to this, it was suggested that particular mares produced 
multiple affected offspring (Errington, 1938).  Finally, there are numerous anecdotal 
reports predominately within Thoroughbred horses, but other breeds as well, of 
particular sires or dams that seem to produce an increased number of CSM progeny.   
There are also published papers to the contrary, where investigators reached 
a conclusion that genetic determinants have a limited role in the development of 
CSM.   Pedigrees of British Thoroughbreds with CSM were examined in comparison 
to controls (Falco et al., 1976).  It was noted there was no increase in disease 
incidence in closed inbreeding populations, arguing against a simple recessive mode 
of inheritance.  Additional smaller studies found no support for inheritance as well 
(Steel et al., 1959; Jones et al., 1954; Schultz et al., 1965).  Wagner and colleagues 
(Wagner et al., 1985) conducted a prospective breeding study crossing dams and 
sires each with a confirmed diagnosis of CSM.  Progeny were closely monitored with 
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serial neurologic examinations and radiographs for the onset of neurological deficits 
up to one year of age.  None of the foals developed CSM during this study period.  
However, an increased incidence of other developmental orthopaedic diseases were 
noted such as physitis, contracted tendons, and osteochondrosis.  This study 
effectively ruled out a simple mode of inheritance for CSM, but it is still possible CSM 
might be one clinical manifestation of a complex hereditary disease.   
The current study was designed to test the hypothesis that inherited genetic 
determinants contribute to the susceptibility or pathogenesis of CSM.  Identification 
of possible associations between single nucleotide polymorphisms (SNPs), 
haplotypes, and copy number variants (CNVs) with the CSM phenotype was carried 
out using both population- and family-based approaches. 
 
Materials and Methods 
 
Experimental Samples 
 
SNP Association Sample Selection: 
A total of 59 Thoroughbred horses with CSM were identified for study.  Study 
subjects were limited to Thoroughbreds to eliminate breed as a variable and reduce 
confounding genetic heterogeneity unrelated to CSM.  Two different phenotyping 
levels were used for identification of CSM cases (Figure 4.1).  Fully phenotyped 
horses underwent antemortem and postmortem examinations as was previously 
outlined in chapter 2 of this thesis.  A second classification level of CSM cases was a 
clinical diagnosis cohort.  These horses were identified based on neurologic 
examination and standing cervical radiographs that strongly supported a clinical 
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diagnosis of CSM.  Also, a subset of horses in this group had a myelogram and/or 
surgical intervention.  For all CSM study subjects, clinical diagnosis needed to be 
made by 5 years of age.  The control group was composed of 6 fully phenotyped 
horses that had no clinical neurological deficits and no evidence of spinal cord 
pathology on postmortem, as well as archived SNP data from 427 general 
population Thoroughbreds genotyped for reasons unrelated to CSM. 
Figure 4.1:  Summary of the phenotypic assessment and signalment parameters for 
CSM horses in the study. 
 
CNV Association Sample Selection 
A Thoroughbred family with an increased incidence of CSM was identified for 
CNV analysis (Figure 4.2).  This family was also included in the SNP analysis.  All 
CSM horses within the family were phenotyped at the clinical diagnosis level.  
Absence of the CSM phenotype in the other progeny labeled as ‘control’ was inferred 
based on productive athletic careers in racing and personal correspondence.  Two 
progeny, one CSM and one control have the same sire.  This sire was also analyzed. 
 
Fully Phenotyped: Clinical neurologic examination, standing cervical 
radiographs, postmortem confirmation of cervical spinal 
cord compression  
Clinical Diagnosis: Clinical neurologic examination, standing cervical 
radiographs, myelogram and surgery in subset of cases  
Breed Examined: Thoroughbred only 
Age Parameter: Clinical CSM diagnosis made at 5 years of age or younger 
Gender of Cases: 53 males; 6 females 
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Figure 4.2:  Pedigree of family included in CNV and SNP analysis.  The solid blue fill 
indicates the horse was included for analysis.  The phenotype status for known 
progeny is listed as CSM or control.  Open shapes with no CSM or control 
categorization indicate the specific phenotype for that horse is unknown.  * indicates 
the same sire for both progeny.  This sire is included for analysis as well. 
 
DNA Isolation 
 Whole blood samples were collected in ethylenediaminetetraacetic acid 
(EDTA) tubes from CSM horses, the 6 fully phenotyped controls, and the family 
samples.  Genomic DNA (gDNA) was extracted using the Gentra Puregene Blood kit 
and protocol from Qiagen (Germantown, MD).  Spectrophotmetric analysis 
(Maniatis, 2012) was used to quantify gDNA and assess purity.  Samples were 
diluted to 100ng/μl ± 10ng/μl for genotyping submission. 
Genotyping 
SNP Genotyping Arrays 
 For SNP genotyping, both the Equine SNP50K Bead Chip (Illumina), 
composed of 54,602 SNPs, and the Equine SNP70K Bead Chip (Illumina), which 
contains 65,157 SNPs, platforms were used.  Polymorphisms are distributed across 
the autosomes and X and Y chromosomes, but these chips contain only  two Y 
chromosome SNPs.  Between the two platforms 45,703 markers are shared.  
Samples were sent to Geneseek (Omaha, NE) for genotyping.  A summary of the 
phenotype classification and array used is given below (Figure 4.3). 
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Figure 4.3:  Summary of the samples genotyped on each array.  The number of 
samples and phenotype classification is provided. 
 
CNV Array 
 Genomic DNA samples from the family samples (Figure 4.2) were run on a 
custom designed exome tiling array (Doan et al., 2012).  The array consists of 
418,576 unique oligonucleotides distributed across all autosomes and the X 
chromosome (Agilent Technologies Inc.).  Oligonucleotides range from 45-60bp in 
length.  Preparation of gDNA samples for comparative genomic hybridization was 
performed according to a published protocol (Doan et al., 2012).  Arrays were 
scanned on an Agilent High Resolution Microarray Scanner 62505C (Agilent 
Technologies Inc.).  Feature extraction 10.5 software (Agilent Technologies, Inc.) 
was used to extract data. 
Quality Control for Data Analysis 
SNP Array Quality Control 
 Genotype data from both 50K and 70K arrays were merged for data analysis.  
Quality control and association analyses were performed using the SNP Variation 
Suite (SVS) version 7 software (Golden Helix Inc.).  SNPs were excluded based on 
genotyping rate < 0.90, minor allele frequency <0.01, and Hardy Weinberg 
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equilibrium p value < 0.001 thresholds.  After these filters, 33,729 SNPs were left for 
analysis.  Samples were also checked for gender discrepancy.  Nine samples from 
the general population data were excluded for indeterminate gender assignment 
based on data provided.   
Identification of Cryptic Relatedness and Population Structure 
 For identification of cryptic relatedness, a genomic best linear unbiased 
predictor (gBLUP) relationship matrix was constructed (vanRaden, 2008).  The 
kinship matrix was based on genotypes and corrected for gender.  This matrix 
functions to control for relatedness between samples that can lead to spurious 
associations.  Population structure, another variable that can lead to spurious 
association, was addressed using principal component analysis (PCA).  The first 
principal component was determined to be the best correction for structure and 
was used as a covariate in the association study (Figure 4.4).  Inclusion of the first 
principal component in the mixed model produced the lowest Bayesian Information 
Criterion (BIC) value (Segura et al., 2012).  
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Figure 4.4:  Scatter plot of 1st and 2nd principal components.  The overlay of case and 
control samples supports minimal population structure in the data set.  Control 
horses are blue diamonds.  CSM horses are green diamonds. 
 
CNV Array Quality Control 
 All arrays passed quality control checks using the feature extraction software 
for uniform signals in spots, background noise, and signal intensity achieving “good” 
or “excellent” assessments.   
 
Statistical Analysis 
Mixed Model Analysis for SNP GWAS 
 A mixed model analysis approach for additive effects was used for the SNP 
genome wide association analysis.  This approach allows for the incorporation of 
fixed and random effects while correcting for relatedness.  The multi-locus mixed 
model (MLMM) option was selected in SVS given the likelihood of CSM being 
controlled by a complex of multiple variants (Segura et al., 2012).  The kinship 
matrix was included in the model along with the first principal component and 
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gender as covariates. A p value of < 0.05 after the Bonferroni correction was 
determined to be significant. 
Haplotype Analysis 
 A case control association analysis was also performed evaluating haplotypes.  
This analysis was performed in SVS using precomputed haplotype blocks.  The 
precomputed block method defines haplotype block boundaries using a confidence 
interval algorithm for identifying linkage disequilibrium (Gabriel et al., 2002).  This 
method identified 4,790 variably sized blocks.  A second method defined haplotype 
blocks based on a sliding window of 5 markers moving along all SNPs regardless of 
the degree of linkage disequilibrium.  It defined 33,697 haplotype blocks.  The Chi 
squared statistic with both the Bonferroni correction and 10,000 full scan 
permutations for multiple testing correction were computed.  A p value of < 0.05 
after either the Bonferroni correction or 10,000 maximum permutations was 
identified as significant.  The Bonferroni correction is calculated by dividing the 
number of samples by the total number of tests.  In this case, each SNP represents an 
individual test.  Haplotype frequencies were computed using EM estimation 
(Dempster et al., 1977; Excoffier and Slaton, 1995). 
Copy Number Variant Identification 
 Copy number variants from the dam in the family pedigree (Figure 4.2) were 
called in Agilent Genomics Workbench 5.  The aberration detection method 2 (ADM-
2) algorithm identified CNVs in respect to a reference sample.  The reference sample 
was a male Thoroughbred defined as a control based on absence of neurologic signs 
and lesions consistent with CSM on clinical and postmortem examination.  The list of 
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CNVs detected in the dam was compared to the equine (various breeds) CNV 
database at Texas A&M for identification of aberrations unique to the mare.  These 
dam-specific CNVs were then analyzed for segregation to her progeny and level of 
association with the CSM phenotype.  
Results 
Correction for Relatedness and Population Structure:   
In order to account for possible spurious associations due to cryptic 
relatedness among samples or possible population structure, gBLUP and PCA were 
used respectively.  Q-Q plots were constructed to evaluate the effectiveness of these 
two methods (Figure 4.5).  In the plot on the left there is a gradual deviation of SNPs 
from the line indicating genomic inflation that could lead to false positives.  The plot 
on the right is the data after correction, where SNPs follow the line until the distinct 
upward deviation at the lowest P values.  These methods appeared to have 
sufficiently corrected for relatedness and structure in the data set.   
             
Figure 4.5:  Q-Q plots before and after methods for structure correction.  Each blue 
box represents an individual SNP.  The plot on the left is the data without correction 
and a gradual deviation from the line is observed consistent with inflation.  The plot 
on the right is after the use of gBLUP and PCA and the inflation has resolved. 
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Chestnut Coat Color Association 
 Coat color information based on individual registration records from the 
Thoroughbred breed organization was acquired for each horse.  This information 
was used to run a chestnut coat color association analysis as a positive control for 
the data set.  The association identified a significant association on ECA 3 in the 
region of the MC1R gene, which is known to control the chestnut coat color 
phenotype (Figure 4.6). 
 
Figure 4.6:  Manhattan plot for chestnut coat color association analysis.  Each 
colored box represents an individual SNP.  The negative log of the p value is 
displayed on the y-axis scale.  Position along the x-axis indicate the individual 
equine chromosomes.  The red line defines significance based on the Bonferroni 
correction for multiple testing.  A strong peak of SNPs in linkage disequilibrium is 
observed on ECA 3 in the region of the MC1R gene known to control for the chestnut 
coat color phenotype. 
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SNP-based Association Analysis 
Results of the SNP mixed model analysis with additive effects identified two 
SNPs with association to the CSM disease phenotype.  Significance was assigned 
based on p < 0.05 after the Bonferroni correction.  SNPs are located on ECA 12 and 
ECA X (Figure 4.7).   
 
Figure 4.7:  Manhattan plot for mixed model analysis with additive effects. The red 
line indicates significance based on the Bonferroni correction for multiple testing.  
SNPs on ECA 12 and ECA X are positioned above the significance threshold. 
 
The allele frequencies and distribution of genotypes of the significant SNPs 
identified in the mixed model analysis between the case and control groups are 
summarized in the table below. 
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SNP ID Location (Chr.bp) P value Genotype Cases n=59 Controls n=424 
BIEC2_193603* 12.22368861 4.17e-10 AA 32 (54.2%) 340 (80.2%) 
   AG 24 (40.7%) 72 (17.0%) 
   GG 3 (5.1%) 3  (0.71%) 
BIEC2_1109022 X.8192913 7.07 e-7 AA 40 (68.0%) 351 (83.0%) 
   AC 4 (6.7%) 50 (11.9%) 
   CC 15 (25.4%) 23 (5.0%) 
Table 4.1:  Summary of the location and genotypes of significant SNPs in the mixed 
model analysis.  *Control group had 9 samples for which the genotypes of 
BIEC2_193603 were not called.  Chr = chromosome; bp = base pair. 
 
Haplotype Analysis 
Significant haplotypes were identified using both the precomputed block and 
sliding window of 5 makers.  In one or both approaches, significant haplotypes were 
identified that included the two individual significant SNPs on ECA 12 and ECA X.  
The location of significant haplotypes using both methods is depicted below (Figure 
4.8 and 4.9).  Estimated haplotype frequencies were also calculated (Table 4.2 and 
4.3).  Significant haplotypes varied between 5.9%-28.81% in the CSM group; 
whereas the haplotype frequency in the control group was below 11.1%.  The 
degree of linkage disequilibrium (LD) varied in the regions covered by the 
significant haplotypes. 
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Figure 4.8:  Manhattan plot of haplotypes using blocks defined by the precomputed 
block method.  The red line indicates significance after applying the Bonferroni 
correction.  The y-axis is the Chi squared statistic.  Each individual box presents the 
first SNP in each haplotype. Significant haplotypes are located on ECA 10 and ECA X. 
 
 
 
Chr Basepair Haplotype Overall Freq 
CSM 
Freq 
Control 
Freq 
Bonf p 
value 
Perm. p 
value 
ECA X* 7,959,875-8,192,913 AGAAC 13.23% 28.80% 11.07% 0.001 0.055 
ECA 10 80,425,724-80,478,372 GAGA 13.71% 6.14% 0.72% 0.038 0.235 
Table 4.2:  Summary of the significant estimated haplotypes identified by the 
precomputed block of markers.  *Indicates haplotype contains significant SNP from 
individual SNP analysis.  Freq.= frequency; Bonf.= Bonferroni; Perm.= permutation 
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Figure 4.9:  Manhattan plot of haplotypes using blocks defined by a sliding window 
of 5 markers.  The yellow line indicates significance of p < 0.05 after applying the 
10,000 maximum permutations of the data.  The red line indicates significance after 
applying the Bonferroni correction.  The y-axis is the Chi squared statistic.  Each 
individual box presents the first SNP in each haplotype. Significant haplotypes are 
located on ECA 2,6,12,16,27, X. 
   
 
Chr Basepair Haplotype Overall Freq 
CSM 
Freq 
Control 
Freq 
Bonf p 
value 
Perm. p 
value 
ECA 2 98,861,186-98,960,646 AGCGG 2.51% 12.39% 1.13% 4.46e-8 0.002 
ECA X 5,790,320-5,983,253 AAAAG 1.46% 6.90% 0.71% 0.029 0.360 
ECA X* 7,963,553-8,196,534 GAACA 13.3% 28.81% 11.10% 0.016 0.299 
ECA X 9,204,707-9,322,958 CAGGA 3.20% 13.12% 1.81% 1.34e-5 0.023 
ECA X 11,478,740-11,558,592 AGAGC 2.36% 11.02% 1.06% 1.48e-6 0.008 
ECA X 80,036,076-81,737,962 AAAAA 3.83% 15.79% 2.13% 2.73e-7 0.004 
ECA 6 37,546,839-38,002,001 GGGAA 1.57% 8.65% 0.64% 9.91e-5 0.044 
ECA 27 30,165,151-30,499,043 GCCAG 1.04% 5.91% 0.36% 0.004 0.170 
ECA 16 17,568,806-17,754,789 GAAGG 1.22% 6.32% 0.51% 0.042 0.418 
ECA 16 52,363,165-52,401,989 GGACG 3.80% 12.65% 2.60% 0.006 0.212 
ECA 12* 22,162,774-22,688,422 AGGGG 1.50% 6.63% 0.74% 0.043 0.421 
Table 4.3:  Summary of the significant estimated haplotypes identified by the sliding 
window of 5 markers.  *Indicates haplotype contains significant SNP from individual 
SNP analysis.  Freq.= frequency; Bonf.= Bonferroni; Perm.= permutation 
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One megabase windows on either side of significant regions were used to 
curate lists of protein coding genes, pseudogenes, and other elements (Table 4.4). 
Ensembl.org was used to identify these elements.  
Gene Summary 
Chr Basepair Protein Coding Pseudogenes Types of RNA 
ECA 2 98,861,186-98,960,646 2 4 2 
ECA X 5,790,320-5,983,253 10 7 0 
ECA X* 7,963,553-8,196,534 9 0 2 
ECA X 9,204,707-9,322,958 16 1 3 
ECA X 11,478,740-11,558,592 22 8 1 
ECA X 80,036,076-81,737,962 59 17 3 
ECA 6 37,546,839-38,002,001 35 9 0 
ECA 27 30,165,151-30,499,043 2 1 2 
ECA 16 17,568,806-17,754,789 9 3 0 
ECA 16 52,363,165-52,401,989 12 9 3 
ECA 12* 22,162,774-22,688,422 73 22 12 
ECA 10 80,425-724-80,478,372 12 3 0 
Table 4.4:  Summary of protein coding genes, pseudogenes, and RNA elements in 
significant loci.  The window used for identifying these elements extends 1 MB on 
either side of the stopping points of the basepair column.  * indicates this region 
contains a significant SNP from the individual SNP analysis. 
 
 
CNV Identification 
 A total of 276 CNVs were called in gDNA from the dam of the previously 
described family pedigree (Figure 4.2).  When compared to the equine CNV database, 
this mare had 207 unique aberrations (Figure 4.10).  Unique is defined as CNVs 
identified in the mare only and not present in the database.  Sixty-nine CNVs were 
identical between the mare and common CNVs in the database.  Finally, 4,987 CNVs 
in the database were not identified in the mare.  Three CNVs were found to 
segregate with the CSM disease phenotype (Table 4.5).  Of these 3, an amplification 
on ECA 9 has not been described previously as a locus for CNV polymorphism.  
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Whereas the other two, both of which suggest heterozygous deletions on ECA 7, 
were located at loci already listed in the equine CNV database. 
 
Figure 4.10:  Venn diagram of unique common CNVs between the dam and the 
database.  The yellow circle represented CNVs called in the dam.  The blue circle 
represents CNVs from the database.   
 
Chromosome Start base pair Stop base pair Direction 
ECA 7 34,644,877 34,682,871 Deletion 
ECA 7 52,736,448 52,736,967 Deletion 
ECA 9 31,306,365 31,306,958 Amplification 
Table 4.5:  Summary of CNVs in the dam that segregates only with CSM progeny.  
Two deletions on ECA 7 and one amplification on ECA 9 were identified in all CSM 
horses in this family. 
Discussion 
 The focus of these experiments was to re-examine the long-standing question 
regarding the role of genetic determinants in the etiology and/or pathogenesis of 
CSM using genome-wide assessments of polymorphic DNA markers.  This was 
accomplished by performing GWAS analyses to evaluate SNP and haplotype 
associations between horses with CSM and the general Thoroughbred population.  
Results of this analysis identified multiple significant loci associations distributed 
across the genome supporting a genetic contribution in some fashion to the etiology 
69   207 4,987 
 
 
87 
and/or pathogenesis of CSM.  Significant SNPs identified on ECA 12 and X were also 
included in significant haplotypes.  In addition, significant loci were identified on 
ECA 2, 6, 10, 16, and 27.  
 An important consideration is what can be determined from the data in 
regards to the possible inheritance pattern.  The GWAS for the CSM disease 
phenotype, assessing both individual SNPs and haplotypes, identified significant loci 
across multiple chromosomes.  This finding is not consistent with a simple mode of 
inheritance, but instead, suggests a more complex genetic trait.  These data are 
supportive of earlier pedigree and breeding studies (Dimock, 1950; Errington, 1938; 
Weischer, 1944; Wagner et al., 1987) that also concluded a simple mode of 
inheritance was unlikely.  The multiple associations with CSM is in contrast to the 
single strong focal peak observed for chestnut coat color, composed of numerous 
SNPs on ECA 3 in the region of the MC1R gene known to regulate the chestnut 
phenotype with a recessive mode of inheritance (Marklund et al., 1996).  
For complex traits, often there are multiple genomic loci and variants 
involved that individually have a small effect, but in combination can reach a 
threshold affecting the phenotype (McCarthy et al., 2008).  Complex diseases in the 
human literature include Crohn’s disease and type 2 diabetes (Bao et al., 2013; 
Tsianos et al., 2012), where multiple genetic loci in combination with environmental 
factors lead to manifestation of clinical disease.  CSM is most likely a similar 
situation.    Established environmental factors that contribute to CSM include high 
planes of nutrition and increased growth rates.  The model predicts environmental 
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factors and inherited genetic variants interacting in potentially complex ways to 
produce the CSM disease phenotype.   
SNPs and haplotypes significantly increased in CSM over controls are 
candidate susceptibility or risk loci.  Conversely, polymorphic markers found to be 
significantly increased in control horses may be close to genes that influence 
protective mechanism.  Regions on ECA 12 and ECA X are particularly interesting 
given they were significant on the analysis of both individual SNPs and haplotypes.  
One megabase genomic intervals on either side of significant SNPs and haplotypes 
were examined for possible genes of interest (Table 4.4).  Genes identified in these 
regions were associated with a variety of ontologies.  One specific gene of interest, 
neuronal membrane glycoprotein gene (GPM6B) located on ECA X, has been shown 
to regulate osteoblast function and bone formation (Drabek et al., 2011).  GPM6B 
controls cytoskeleton formation and matrix vesicle release for mineralization.  
Osteosclerosis, increased bone density due to the presence of excessive 
mineralization, is a pathologic lesion associated with CSM (Mayhew, 1978; Powers 
et al., 1986; Chapter 3).  Therefore, GPM6B could be a gene of interest for future 
studies.    
Identification of regions of interest on the X chromosome is potentially 
interesting given the prominent gender bias of male over females in this disease.  
Since males are hemizygous for the X chromosome, they will express an X-linked 
disease whether it is dominant or recessive.  It is unlikely that CSM is completely 
explained by an X linked inheritance, but the potential contribution of the X 
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chromosome and the documented male over female bias is interesting.   A role for 
the X chromosome is also intriguing given anecdotal evidence of “unaffected” dams 
producing CSM offspring. 
The CNV experiment looked for association of specific copy number variants 
with the CSM disease phenotype.  The family studied is unusual given the increased 
number of affected horses, since the overall prevalence of CSM in the Thoroughbred 
population is estimated at 2% (Oswald et al., 2002).  It is possible this mare could 
have additional or even unique de novo mutations contributing to the high incidence 
of disease observed.  In a preliminary analysis of the CNV data, the index mare 
contains 207 unique CNVs relative to an equine CNV database (Figure 4.10).  This 
database is comprised of data from a multiple horse breeds (Scott Dindot and Cole 
McQueen- personal communication), therefore variation unique to the 
Thoroughbred is likely included in this group of CNVs.  Three of the mare’s CNVs 
were inherited only by the foals that developed CSM (Table 4.7).  Current annotation 
of these loci is limited to genes encoding uncharacterized proteins.    
Several studies have identified the occurrence of osteochondrosis (OC) in 
cervical vertebrae of horses affected by CSM (Mayhew et al, 1978; Stewart et al, 
1991; Chapter 3).  OC is another multifactorial musculoskeletal disease where the 
role of genetic determinants has been examined in various horse breeds (Distl, 
2013 ; Corbin et al., 2011, Wittwer et al., 2007; Dierks et al., 2010; Felicetti et al., 
2009; Lampe et al., 2009).  Multiple loci have been identified across the genome 
with significant association to the OC phenotype.  Given that many pathological 
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lesions in the articular joints of cervical vertebrae of CSM horses are OC, the 
previously published SNPs from the GWAS studies of equine OC were compared to 
loci found in the current CSM analysis.  No concordance between regions of interest 
of the two diseases was found. 
Given limitations in the number of CSM samples evaluated, an important 
point to consider in the current dataset is statistical power.  While sufficient horses 
were analyzed to detect a trait regulated by a single gene with a recessive mode of 
inheritance, as clearly demonstrated with chestnut coat color, the assembled sample 
set may not be sufficient to resolve complex genetic determinants for CSM.  When 
investigating complex genetic traits in genome wide studies, a larger sample size is 
required for sufficient power to identify variants that individually have a smaller 
effect.  In this study, a larger general population data set was used for the control 
group in an effort to more confidently establish SNP frequencies in the 
Thoroughbred for comparison to the CSM samples.  Also, it is important to note that 
the general population Thoroughbreds used for controls were genotyped for 
reasons unrelated to CSM.  As such, we cannot be sure that all of these horses were 
free of neurological deficits.  Any horses with CSM in the control population sample 
set would also diminish statistical power.  
Analysis in this study combined SNPs from two commercial Illumina 
platforms, the 50K and 70K equine chips.  Therefore, it is possible there may be a 
chip bias.  The PCA plot demonstrated decent overlay of the 50K and 70K horses 
indicating bias might be less of an issue.  That being said, some of the significant 
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haplotypes in the sliding window analysis were heavily represented on one chip 
versus the other making them less convincing compared to other identified loci.  
Haplotypes identified in the sliding window analysis distributed on samples from 
both chips include ECA 6, 27, and X. giving these regions support and priority for 
further validation and investigation. 
In addition to sample size contributing to lack of power, a smaller number of 
SNPs was evaluated since only those common to both chips were used.  One method 
to address this issue would be imputation.  Imputation gives the probability of a SNP 
at an ungenotyped location based on the LD of the variants surrounding it.  An 
imputation mechanism for the 50K and 70K Equine Bead Chips has been put forth in 
the literature (McCoy et al., 2013).  This method would allow for evaluation of all 
horses in the sample set at approximately ~65,000 SNPs before filtering versus the 
~33,000 SNPS analyzed currently.  Increasing the number of SNPs evaluated allows 
for denser coverage of the genome and would facilitate locating significant variants 
that contribute to CSM. 
Additional studies will enable further refinement of loci identified in this 
work.  First, a new and independent population of CSM and control horses is needed 
for validation of these regions.  Another issue that may be critically important is 
refinement of phenotyping parameters.  In other words, CSM could represent a 
common clinical syndrome that results from more than one pathogenic mechanism.  
The anatomical structures of the vertebrae that can participate in canal stenosis are 
variable (i.e. articular processes, vertebral body subluxation, epiphyseal flaring, or 
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extension of the dorsal lamina).  As such, it may be better to assess each type of 
vertebral malformations independently by assembling CSM sample sets based on 
specific vertebral malformations.  Attempts to define phenotypic subcategories with 
the current sample set did not improve GWAS resolution, likely because this 
subgrouping further reduced the number of CSM cases available for comparison.  
This is the first study to investigate the role of inherited genetic determinants 
in equine CSM using a genome-wide analysis of gDNA polymorphisms.  Data support 
the contribution of genetic determinants to the development of disease.  Control of 
the CSM phenotype by one major gene is improbable, as multiple significant loci 
were identified across the genome.   Therefore, it is likely instead that CSM is a 
complex genetic trait with the phenotype influenced by multiple genes and several 
environmental variables.  Subsequent studies validating loci and investigating the 
role of these variants and any other contributing factors is warranted.  Also, the 
interaction of genetic and environmental variables is an additional investigative 
point for consideration in future efforts to elucidate the etiology and pathogenesis of 
CSM.  
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Chapter 5 
Reflections and Looking Ahead to Future Studies 
Reflections 
 Research efforts in this dissertation thesis were aimed at examining 
important questions related to the etiology and pathogenesis of equine CSM.  The 
specific objectives were: 1) compare the ability of MRI and standing cervical 
radiographs to detect and localize cervical vertebral canal stenosis in CSM horses, 2) 
evaluate the frequency and severity of skeletal lesions identified by MRI in the 
articular processes of cervical vertebrae in CSM horses, 3) characterize the lesions 
in articular processes of CSM horses on structural and histological levels, and 4) 
investigate the role of inherited genetic determinants in CSM.   
CSM remains a major problem in various equine breeds including 
Thoroughbreds, Warmbloods, and Tennessee Walking Horses to name a few.  Since 
CSM often results in substantial neurologic deficits, it has a significant impact on the 
welfare of the horse.  Justification for the re-examination of CSM etiology and 
pathogenesis in the context of my PhD dissertation are three-fold.  First, these issues 
are of fundamental importance for efforts to improve the diagnosis, management, 
and/or treatment of this disease.  In other words, research on these issues has the 
potential to have a near-term, real-world impact.  Second, technological advances in 
equine science have been achieved in recent years in areas related to diagnostic 
imaging and genomics.  Working with these technologies provided a valuable 
educational opportunity for me and increased the potential that the research would 
yield results with a positive impact for horses.  Finally, this dissertation research 
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focus has allowed me the opportunity to advance my interests in anatomic 
pathology and the equine musculoskeletal system while achieving the primary 
educational goal of PhD level training in experimental biology.  The project has 
provided direct synergy of my educational priorities to continue to develop as a 
veterinarian pursuing clinical diagnostic and discovery science interests. 
 In chapter 2, the hypothesis was tested that MRI is superior to standing 
cervical radiographs for identification and localization of canal stenosis.  It was felt 
MRI could potentially improve the specificity and sensitivity of stenosis diagnostic 
assessment given the ability to obtain multiple views of the cervical column as 
compared to standing cervical radiography.  The morphometric assessment of the 
vertebral column on MRI identified canal area and the cord to canal area ratio as 
useful metrics for determination of compression.  Indeed, when compared to 
standing cervical ratios, both canal area and CCAR on MRI demonstrated an 
improvement in spinal cord compression localization.  The data supported the 
hypothesis originally put forth.  There are limitations of this study that need to be 
addressed in further studies.  First, canal area and CCAR need to be evaluated in 
both the extended and flexed neck position.  Our study was limited to the neutral 
position.  On myelography, it has been demonstrated that there are cases where 
cord compression is only visualized in the extended or flexed position.  Secondly, 
additional horses need to be evaluated to enable the establishment of thresholds for 
stenosis in a clinical setting.  With increased numbers and statistical power, a 
Receiver Operating Characteristic (ROC) curve could be constructed to determine 
sensitivity and specificity and identification of possible cutoffs for each vertebral 
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site.  The establishment of thresholds for canal area and CCAR would allow for 
application in the diagnostic setting as technology continues to evolve to 
accommodate imaging of the equine cervical column antemortem. 
 Experiments reported in chapter 3 use this same MRI primary dataset to 
evaluate bone and cartilage pathology in the articular processes of CSM horses.  The 
study quantified an increased number and severity of lesions relative to controls, 
followed by histological and microstructural assessments of pathological changes in 
the lesions.  The findings support a generalized bone and cartilage developmental 
issue of the cervical column, in which pathology is not limited to only the site of 
compression in horses with CSM.  A subset of lesions evaluated structurally and/or 
histologically found osteochondrosis, osseous cyst-like structures, fibrous tissue 
replacement of trabecular bone and bone marrow, and osteosclerosis.  The data are 
consistent with primary skeletal developmental issues, associated with secondary 
biomechanical stresses on the vertebral column leading to CSM pathology in the 
articular processes.  It is important to note that growth plates in equine vertebrae 
do not close until 4-5 years of age, so CSM normally develops and becomes clinically 
apparent while horses are still very much in a phase of growth and maturation.  
Prior to growth cessation, the vertebrae are likely more responsive to the abnormal 
biomechanical forces.   
Analyses of the pathological lesions have provided important new 
information about equine CSM.  Most notably, these include pathologic lesions 
identified regardless of compression site and descriptions of novel osseous cyst-like 
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lesions present in the articular processes.  Further studies are needed to determine 
if similar pathology is observed in other parts of the vertebrae and appendicular 
skeleton.  If this occurs, it would further support a generalized defect in bone and 
cartilage morphogenesis and/or maturation.  
 The long-standing question that probably generates the most interest among 
equine veterinarians and horse owners is the extent to which inherited genetic 
determinants are an important variable in the etiology, pathogenesis, and/or 
susceptibility of horses to this disease.  It really is an important issue to re-
investigate, given that the entire equine genome has now been sequenced and 
related genomic DNA analytical reagents are now available.  The hypothesis tested 
was that there are inherited genetic determinants that contribute to the 
susceptibility of CSM in the horse.  A genome wide association study (GWAS) using 
single nucleotide polymorphisms (SNPs) and haplotypes was performed.  Multiple 
significant loci associating with the CSM phenotype were identified across the 
genome supporting the role of genetic determinants in clinical disease.  Control of 
CSM by a single gene consistent with a simple Mendelian trait is unlikely given the 
results of this study.  Instead, the identification of multiple loci supports a complex 
trait.  Complex traits are influenced by multiple genes and the phenotype does not 
follow simple Mendelian patterns of inheritance.  Many complex traits are also 
regulated by environmental variables.  Findings from the current work are generally 
consistent with earlier research from other groups, indicating that equine CSM is a 
multi-factorial disease.  Importantly, these data can also serve as a starting point for 
continued investigation of genetic determinants associated with CSM.  Validation of 
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the identified loci using a new and independent sample set is needed as studies 
move forward.  An important point to keep in mind for experimental design of 
subsequent analyses is sample phenotyping.  There are different anatomical ways to 
achieve cord compression that should be considered for subgrouping of samples for 
testing.  Different combinations of genotypes could control the various anatomic 
phenotypes.  Comparison of genotypes across the types of compression would 
identify if there were genetic heterogeneity associated with CSM as well.  
 Experiments in this dissertation provide support for the role of genetic 
determinants in CSM.  The next logical step is fine mapping of validated regions with 
either a high density SNP array or targeted genome sequencing for further 
refinement.  This would allow for identification of strong candidate genes.  Another 
approach is the use of whole genome sequencing of a family with multiple affected 
individuals, such as the family described in chapter 4.  The cost of whole genome 
sequencing has fallen in recent years making it potentially feasible for studies with 
smaller sample sets.  It would allow for identification of multiple variants in protein 
coding genes and regulatory elements.  There are logistical considerations that 
would need to be considered with whole genome sequencing such as cost, number 
of animals, and mechanisms to confidently identify variants associated with the 
disease phenotype.  However, if possible it could be a powerful tool for further 
refinement of the role of genetic determinants in CSM. 
Although establishment of equine CSM as a multi-factorial disease makes 
issues related to etiology, pathogenesis, and susceptibility more complex, it also 
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identifies important strategies for research going forward.  One example would be 
to search for epigenomic factors.  Epigenetics is the field of science that focuses on 
changes in gene expression without alterations in the DNA nucleotide sequence.  
Multiple studies have confirmed alterations in environmental factors, specifically 
nutrition, can lead to epigenetic modifications affecting disease susceptibility (Wolff 
et al., 1998; Waterland et al., 2003).  Also, it has also been demonstrated that 
epigenetic signatures can be inherited (Jirtle and Skinner, 2007).  By investigating 
the interaction between environmental and genetic variables in equine CSM, it could 
provide valuable new insights about this disease. 
Given the evidence that developmental issues of bone and cartilage 
morphogenesis and/or maturation have an important role in CSM pathogenesis, 
investigation of the cervical column during gestation and the early postnatal period 
will almost certainly be of value.  There have been reports of subclinical stages of 
osteochondrosis in late gestation (Olstad et al., 2011).  It is possible that 
predisposition for vertebral malformation could begin in utero.  Identification of 
critical time points of cervical vertebral development would be useful for 
establishing windows when the vertebrae are susceptible to influences leading to 
malformations.   
The obvious clinical relevance of continuing to address factors implicated in 
the etiology and pathogenesis of CSM is improved diagnosis, management, 
treatment, and even possibly prevention of the disease.  Work in this dissertation 
supports a role of genetic determinants as an etiologic factor in equine CSM.  Future 
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studies need to confirm the identity of important loci and specifically define 
contributing genetic factors.  This will enable genetic risk scores for application to 
management practices and breeding decisions to be developed.  Likewise, further 
understanding of the cervical vertebral column development could identify critical 
time points for optimal implementation of disease modifying management practices.  
Pulling Together our Current Understanding of Equine CSM 
 Organizing published literature and the work from this thesis, it is possible to 
summarize factors that confer an increased or decreased risk of developing CSM 
(Figure 5.1) and pathological changes observed with the disease (Figure 5.2).   
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Figure 5.1:  Risk factors for cervical stenotic myelopathy (CSM).  A variety of factors 
are known or believed to contribute to clinical development of CSM.  Factors listed 
on the left side are associated with a decrease risk of disease, while factors on the 
right in a combinatorial manner increase disease incidence. 
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Figure 5.2:  Vertebral gross and histopathologic changes associated with CSM.  Each 
box represents a particular anatomical structure with listed gross and/or 
histopathologic lesions that have been identified with this disease.  It is important to 
note that while these changes can be seen individually, it is also common to see 
combinations of lesions.     
 
It is much more challenging to develop a working model of CSM etiology and 
pathogenesis.  There are multiple ways to achieve spinal canal stenosis; some paths 
are straightforward while others are likely complex.  A simple path to canal stenosis 
and cord compression would be a horse experiencing a traumatic event that results 
in a cervical vertebral subluxation.  Another relatively straightforward example 
might be a horse developing epiphysitis and flaring of the vertebral growth plates.  
Other pathways, however, will clearly be more complex.   
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Given the strong evidence that development, growth, and maturation of 
cervical vertebrae are important variables, consideration of a timeline should be 
helpful (Figure 5.3).  The figure illustrates important events and time periods in 
comparison to age of CSM diagnosis for 252 Thoroughbred cases.  Genotype of an 
individual is defined at conception.  Skeletal ossification in the equine fetus begins 
around gestational day 37 (Jenner et al., 2014).  By 2 years of age, Thoroughbreds 
have attained approximately 95% of their final height and 90% of the their final 
body weight (Kocher and Staniar, 2013).  Closure of the vertebral growth plates 
occurs between 4-6 years of age (Whitwell and Dyson, 1994, Stephen Reed - 
personal communication).  Osteochondrosis (OC) is generally reported to develop 
between birth and 5 months of age (Carlson et al., 1995; Dik et al., 1999; van Weeren, 
2006), but recent work is also considering cartilage biology in utero (Olstad et al., 
2011).   Environmental variables are relevant throughout these periods. 
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Figure 5.3:  Skeletal growth and maturation timeline in the context of variables and 
pathology associated with CSM.  The timeline is presented from conception to 6 
years of age.  Above the timeline, pertinent points related to general skeletal and 
vertebral growth are indicated.  Below the timeline, the influence of proposed 
etiology factors are depicted.  A survey of the age at CSM clinical diagnosis for 
Thoroughbreds scaled to match the timeline is at the bottom.  
 
CSM remains an important neurologic and musculoskeletal disease of the 
horse and therefore warrants continued research for further understanding of 
disease mechanisms.  With discovery science, the investigation of relevant questions 
often results in generating more questions.  This dissertation thesis is no different.  
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Rapid advances in genomics, diagnostic imaging, and molecular technologies allow 
for continued investigation and hopefully relevant contributions to the 
understanding of CSM.  
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